JG_7的个人主页 - 老虎社区

JG_7

JG_7

暂无个人介绍

IP属地：未知

23关注

14粉丝

1主题

0勋章

2021-12-20

👍

Apple Stock: The Strongest Shield Against Rate Hikes

2021-12-19

Good

Toplines Before US Market Open on Friday

2021-12-19

Good 👍

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows

2021-12-18

Thanks for sharing 👍

3 Warren Buffett Stocks I Like Heading Into 2022

2021-12-16

Great 👍

Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap

2021-12-16

🚀🚀

@AnnieReis:$Pfizer(PFE)$j继续加油! 😁

2021-12-15

Ok

Wall Street ends down, investors eye inflation and Omicron

2021-12-14

Good 👍

Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share

2021-12-10

Good 👍

Brazilian fintech giant Nubank spikes 26% on its first day of trading

2021-12-09

Ok

Wall St closes higher as vaccine update feeds optimism

2021-12-07

Okay //@Ameliakoh:Pls like

After-Hours Stock Movers: HealthEquity,MongoDB,Silvergate,Shineco and more

2021-12-07

Ok

10 Biggest Price Target Changes For Tuesday

2021-12-06

💪💪

抱歉，原内容已删除

2021-12-03

👌

抱歉，原内容已删除

2021-12-03

//@Abbas99m:Wow

Crypto stocks slid in morning trading

2021-12-02

👌 okay

5 Top Stocks To Buy in December

2021-12-02

👍

What Shareholders Can Expect From Musk’s New Tesla Roadmap

2021-12-01

Good 👍

5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market

2021-11-24

👍

抱歉，原内容已删除

2021-11-16

👍

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3578285722323782","uuid":"3578285722323782","gmtCreate":1615191698275,"gmtModify":1706620613519,"name":"JG_7","pinyin":"jg7jg7","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":14,"headSize":23,"tweetSize":68,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.22","exceedPercentage":"60.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":693882918,"gmtCreate":1640001208655,"gmtModify":1640001678281,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693882918","repostId":"1183475424","repostType":4,"repost":{"id":"1183475424","pubTimestamp":1639967829,"share":"https://www.laohu8.com/m/news/1183475424?lang=&edition=full","pubTime":"2021-12-20 10:37","market":"us","language":"en","title":"Apple Stock: The Strongest Shield Against Rate Hikes","url":"https://stock-news.laohu8.com/highlight/detail?id=1183475424","media":"Seeking Alpha","summary":"Summary\n\nWith inflation running its hottest course in 40 years, the Federal Reserve has decided to a","content":"<p><b>Summary</b></p>\n<ul>\n <li>With inflation running its hottest course in 40 years, the Federal Reserve has decided to accelerate the stimulus tapering schedule and prepare for raising interest rates as early as March.</li>\n <li>While rate hikes have historically deterred investors from growth stocks due to concerns over eroding valuation prospects, the Apple stock has remained largely resilient.</li>\n <li>Apple is expected to realize additional upsides ahead, sustained by robust demand for its existing offerings and new opportunities arising from nascent technologies like AR/VR and autonomous vehicles.</li>\n <li>Its strong net cash position also provides sufficient dry powder to fund additional growth in coming years without incurring additional costs of capital amidst rising interest rates.</li>\n <li>As such, Apple's bullish thesis remains intact as it approaches a $3 trillion valuation, despite broader market valuation risks ahead.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fdf73ac36a98ce54b343c7e6b613f4d9\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>guvendemir/iStock Unreleased via Getty Images</span></p>\n<p>As one of the world’s best performing stocks, Apple(NASDAQ:AAPL)&nbsp;has gained close to 40% this year. The stock, which last peaked at $182.13 not too long ago, is currently less than 7% from being the first U.S. publicly listed company to reach a $3 trillion market value and single-handedly accounts for about 15% of the tech-heavy Nasdaq 100’s performance. Apple’s market value has grown by&nbsp;more than 220x&nbsp;since the late 1990s, buoyed by the company’s continuous ability to capture robust demand for its innovative portfolio of products and services.</p>\n<p>And Apple’s strong fundamentals are expected to help the stock defy adverse impacts from the imminent rate hikes beginning next year. With inflation running at its hottest in almost four decades, the Federal Reserve decided Wednesday that it will increase the pace at which it is dialing back on the $120 billion monthly bond repurchasing program from $15 billion per month, which began in November, to&nbsp;$30 billion per month. This would effectively conclude the stimulus program, put in place at the onset of the pandemic, coming March, rather than in&nbsp;July as initially planned. Rate hikes are expected to begin soon after to counter rising price pressures, with Federal Reserve Chair Jerome Powell affirming that the process will only begin after tapering ends and at a gradual pace. The latest dot plot indicates potential for the Federal Fund Rate to lift-off from near-zero beginning early 2022 with three quarter-point increases, plus another three in 2023 and two more in 2024. If materialized, the process would up the funds rate to 2.1% by 2024.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ef3ca2d04c1b55a465e12bfae79890e\" tg-width=\"640\" tg-height=\"315\" width=\"100%\" height=\"auto\"><span>Source: Bloomberg</span></p>\n<p>While rate hikes typically cause investors to turn risk averse due to concerns over&nbsp;faster erosion of value on future gains&nbsp;and stalled business growth due to rising costs of capital, especially for high-growth stocks, Apple gained close to 3% upon release of the Fed’s update on policy tightening. The stock closed at $179.30 on December 15th, nearing its peak of $182 on Monday. Apple’s rally, along with similar uptrends observed across other mega-cap tech stocks, accordingly drove intra-day gains of 2.4% for the Nasdaq 100 following the Federal Reserve’s update, indicating investors’ preference to park their money in companies with robust growth prospects to counter risks from the impending rate increases.</p>\n<p>With the coming holiday season a boon for Apple’s December-quarter sales, the stock’s valuation is expected to enter in the $3 trillion territory sooner than expected. Continued robust demand observed across Apple’s entire product line, generous share buy-backs, and additional revenue contributions expected within the foreseeable future resulting from new, cutting-edge products will also be key catalysts to support the company’s persistently strong fundamentals and keep the stock’s valuation above $3 trillion despite the impending rate hikes. Considering recent developments to the broader market and Apple’s growth prospects, we are raising our 12-month price target for the stock to $209.43.</p>\n<p><b>FY 2021 Overview and Recap of Fundamental Prospects</b></p>\n<p>Fiscal 2021 was a big year for Apple. The company’s revenues for the year grew 33% from fiscal 2020 to $366 billion, despite on-and-off store closures resulting from recurring coronavirus outbreaks and supply chain constraints that have led to more than $9 billion in lost sales. Every product and service segment achieved record-setting revenues with more than 20% growth from previous year results. Much of the year’s success were attributable to a series of new product launches and feature upgrades. The most notable of which included the 5G-enabled family of iPhone 12s and iPhone 13s, as well as the M1-powered MacBook Pro and iPad Pro.</p>\n<p><b>Key Developments in Products</b></p>\n<p>iPhone sales grew by 39% this year, the most amongst other segments, and drove more than half of Apple’s fiscal 2021 revenues. The results were a stark contrast to last year’s slump in demand for the mobile device when consumers braced for pandemic-driven economic uncertainties. iPhone sales are expected to remain robust in coming years as global 5G device upgrades continue to gather pace. The likely launch of a more affordable 5G-enabled iPhone SE in 2022 is also expected to further Apple’s market share gains by&nbsp;attracting switchers&nbsp;from “more than a billion non-premium Android users”, and drive the active installed base to another all-time high. The anticipated momentum is further corroborated by iPhone sales patterns observed in recent quarters following the launch of 5G-enabled iPhone 12s and iPhone 13s, where the number of upgraders and switchers grew by&nbsp;strong double digits. Apple’s strong ties with cell-phone carriers is also expected to drive meaningful iPhone sales contributions in coming years. Reputable wireless carriers in the U.S. like&nbsp;Verizon&nbsp;and&nbsp;AT&amp;T&nbsp;have already been keen on promoting the sale of 5G-enabled devices like the iPhone 12 and iPhone 13 to encourage migration to the 5G network that they have spent billions of dollars on building across the nation. Telecom companies around the world are expected to spend&nbsp;more than $700 billion&nbsp;over the next five years on building-out the 5G network, underscoring significant additional growth opportunities ahead for the iPhone segment as carriers push for the strongest multiyear upgrade cycle in a decade to recoup their investments.</p>\n<p>Mac and iPad sales also grew significantly in fiscal 2021, reaching record revenues of $35.2 billion and $31.9 billion, respectively. Following the introduction of the&nbsp;all-new M1-powered iMac&nbsp;earlier this year, Apple also unveiled the&nbsp;reimagined M1-Pro / M1-Max powered MacBook Pro&nbsp;in October. The custom M1 processors made the newest MacBook “better than any Intel-based device for nearly every productivity use case outside of gaming”. This accordingly drove incredible demand for the portable workstation from a diverse group of consumers, ranging from professional creators and photographers to corporate users and students. The company is estimated to have shipped&nbsp;over 3.2 million units&nbsp;of Mac products during the September quarter, which drove record-setting revenues for the segment, while boosting its rank in global PC sales to fourth place amongst other vendors. The introduction of M1-processors in Apple’s computing products also bolstered its position in capitalizing on the surge in global demand for PCs and multi-purpose tablets by allowing the company to build devices with innovative features that can be seamlessly integrated across its ecosystem of peripheral accessories and services to draw adjacent revenues. With accelerated adoption of hybrid work and study arrangements in the post-pandemic era, global demand for portable workstations like PCs and multi-purpose tablets are expected to remain elevated in coming years – the sectors are expected to grow into a&nbsp;$224.3 billion&nbsp;and$600 billion&nbsp;market, respectively, by 2025, which makes favorable trends for Apple’s Mac and iPad segments.</p>\n<p>Recent speculations on Apple’s intentions to&nbsp;strengthen its in-house chip development capacity&nbsp;will likely further the advancement of its technologies offered in coming years and draw additional demand to its products. The company is currently looking for engineers to build-out its capacity in the development of “wireless radios, radio-frequency integrated circuits, and a wireless system-on-chip (“SoC”)”, as well as “semiconductors for connecting Bluetooth and Wi-Fi”. These developments are expected to further enhance seamless integration across Apple’s devices and increase stickiness to its ecosystem of product and service offerings, making its chip unit one of the company’s “most prized assets”.</p>\n<p><b>Key Developments in Services</b></p>\n<p>On the services front, a strong subscriber base had enabled the segment to hit record-setting revenues of more than $68.4 billion in fiscal 2021, up 27% from the prior year. To date, Apple has garnered more than 745 million paid subscribers across its high-margin service offerings, representing a five-fold increase over the last five years. Apple’s increasing push for a subscription-based business model across its wide variety of service platforms, ranging from Apple Music to iCloud storage solutions, paired with attractive new offerings that address key consumer trends in recent years have been a key driver to the company’s fast-expanding margins. New exciting add-on features introduced for existing service platforms include&nbsp;Spatial Audio and Lossless Audiofor Apple Music and the&nbsp;Apple Music Voice Plan. The new subscription-based offerings are expected to further Apple’s reach to adjacent opportunities stemming from increasing global usage of smartphones, laptops and other advanced home electronic products – for instance, the global music streaming market is expected to expand at a CAGR of 16% towards a&nbsp;projected value of $61 billion&nbsp;over the next five years, underscoring significant growth headroom for Apple Music. And Apple’s latest introduction of the&nbsp;Apple One bundle&nbsp;is expected to be a key contributor to furthering service segment sales in coming years by attracting new users to pay for subscription services that they otherwise would not have had it not been for the bundle discounts.</p>\n<p>Continued growth in market demand for mobile applications will also be a boon to Apple’s fast-growing services segment. The global market for mobile applications is expected to grow at a CAGR of 18.4% and reach a market value of&nbsp;more than $400 billion&nbsp;over the next five years. With AAPL hosting&nbsp;one of the largest and most used app stores&nbsp;in the world, it would be reasonable to assume that related revenues would grow at a similar pace. Despite&nbsp;mounting global regulatory scrutiny&nbsp;over Apple’s alleged antitrust violations with its App Store – the most notable of which stemming from an ongoing&nbsp;legal battle with Epic Games– the company’s continued focus on ensuring user privacy, security, and ease of transactions might have saved the day. According to a survey of 4,000 Apple product users performed by Morgan Stanley across the U.S. and China, most have indicated loyalty to Apple’s App store due to the “value of security, privacy and ease of transactions” provided, despite developers pushing for rights to transact outside of Apple’s ecosystem. Apple’s recent success in&nbsp;delaying App Store changes&nbsp;ordered by U.S. District Judge Yvonne Gonzalez Rogers in&nbsp;September&nbsp;as part of a year-long lawsuit brought against by Epic Games is another sign of the App Store’s continued strength. The company has argued that the court-mandated order to allow App Store users to “buy directly from developers on the web” would be a threat to the security of their privacy.</p>\n<p>Currently, developers are fighting for their rights to have app users transact outside of Apple’s ecosystem, which charges developers a hefty commission fee of up to 30% on all purchases. As Apple continues with its appeal of the ruling, the ultimate court decision on whether App Store changes would need to be implemented could take at least another year. But even with an unfavorable ruling, where Apple would have to allow developers to redirect users to payments outside of its ecosystem and/or lower its in-app purchase commission rate, App Store revenues are only expected to decrease by&nbsp;at most $4 billion per year&nbsp;which will not place a material impact on its valuation prospects. The actual quantified impact might even be less than what the market has forecasted, considering the value that App Store users have ascribed to the level of security and convenience that Apple has offered through the platform.</p>\n<p><b>Key Catalysts Ahead</b></p>\n<p>Apple is undoubtedly a key gateway to bringing emerging technologies to the mainstream due to its massive installed base of devices and related service platform users. And because of this, the highly anticipated launch of cutting-edge products like AR/VR headsets and autonomous vehicles in coming years will likely catapult the stock to new heights. The pioneer of disruptive consumer electronics and devices is expected to launch a&nbsp;VR headset and AR glasses&nbsp;by early 2023, a nascent technology that has been picking up steam in recent months with increasing talks of the metaverse. Similar to most VR headsets already available in the market, Apple’s will feature a 3D display to enable an immersive environment for a variety of activities from gaming to communicating. The differentiating factor will be the company’s plans to implement best-in-class graphics chips in the device to facilitate ultra-high-resolution displays. The impending VR headset will ultimately lay the foundation for its AR glasses, which Apple expects to be the “larger opportunity”.</p>\n<p>Over the next five years, opportunities pertaining to the metaverse are expected to blossom into an&nbsp;$800 billion market. Related software and service sales are expected to drive more than 70% of the projected addressable market, while the remainder will likely be driven by hardware sales. This makes strong tailwinds for Apple, which does not only stand to capitalize on growing metaverse opportunities through the sale of its impending AR/VR headset, but also adjacent revenues pertaining to the usage of related apps, software and service platforms.</p>\n<p>Speculations on Apple’s ongoing development of&nbsp;a self-driving electric car&nbsp;is also expected to materialize into meaningful upsides for the stock within the foreseeable future. The company is now planning to launch the new product category by 2025, at which time the global autonomous vehicle market is expected to reach a value of&nbsp;more than $200 billion. The eventual car will likely feature homages to its existing product portfolio, like an “iPad-like touch screen” infotainment system. And on the technology front, Apple is believed to have completed the development of a custom silicon for powering the vehicle’s autonomous driving capabilities. The newest chips will soon be implemented into its existing fleet of retrofitted SUVs for testing in California according to the state’s DMV, a sign that the impending launch is near.</p>\n<p>While Apple’s current market value may already be reflective of “consistent material revenue contributions from new products and services over time”, additional upsides from the above-mentioned new product category launches are still missing. But this will likely change within the next 12 months as the impending launch of an Apple AR/VR device draws near. Near-term projections on early AR/VR device sales are expected to boost Apple’s valuation by&nbsp;at least $150 billion. And over time when metaverse trends continue to gain mainstream traction, Apple is expected to generate more than $200 billion in annual revenues from the AR/VR segment, which could add another 15% on top of its current market value.</p>\n<p><b>Valuation Prospects and Potential Impacts from the Impending Rate Increases</b></p>\n<p>Adjusting our most recent forecast for Apple’s fiscal 2021 year-end results and December-quarter guidance, our base case projection estimates total net sales of $439.3 billion by the end of fiscal 2022, with further growth towards $668.5 billion by fiscal 2026. The growth assumptions applied across segment revenues in our forecast remains largely unchanged from our&nbsp;most recent analysis&nbsp;on the stock, with additional consideration for management’s near-term outlook on supply constraint impacts and the impending rate hikes. Specifically, lost revenues of $9 billion (i.e. approximately $3 billion during June-quarter and $6 billion during September-quarter) attributable to industry-wide chip shortages and pandemic-driven manufacturing delays during the second half of fiscal 2021 is expected to worsen into the first half of fiscal 2022. While there have been observed improvements to supply chain challenges, continuously robust demand for Apple products is what will drive a higher volume of lost sales in coming quarters. Nonetheless, Apple remains well-positioned for strong fundamentals ahead, which will help to alleviate some of investors’ concerns on valuation due to impending rate hikes.</p>\n<p><img src=\"https://static.tigerbbs.com/b5aa95136cfca6f95b962ea36eadab74\" tg-width=\"640\" tg-height=\"257\" width=\"100%\" height=\"auto\"></p>\n<p><i>i. Base Case Financial Projections:</i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6585b165abd25fab7d171dd944d05156\" tg-width=\"640\" tg-height=\"316\" width=\"100%\" height=\"auto\"><span>Source: Author, with data from our internal financial forecast (Apple_-_Forecasted_Financial_Information.pdf). Please refer here for further detail on material growth assumptions applied.</span></p>\n<p>Drawing on the above considerations, our 12-month price target for the Apple stock has been revised to $209.43. This represents upside potential of more than 22% based on the last traded price of $171.14 on December 17th.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e88e904b5b900fbcdf4541d856570e2d\" tg-width=\"640\" tg-height=\"230\" width=\"100%\" height=\"auto\"><span>Source: Author, with data from our internal valuation analysis.</span></p>\n<p>The revised price target is derived using a discounted cash flow (“DCF”) analysis over a ten-year discrete period in conjunction with the financial projections updated for Apple’s recent developments as analyzed in earlier sections. Similar to our original valuation analysis, we have applied a WACC of 8% to discount Apple’s projected free cash flows. The discount function is reflective of the company’s risk profile, taking into consideration its current capital structure and strong balance sheet. Apple’s cost of capital for growth is not expected to change significantly as a result of the impending rate hikes, considering a large portion of its existing debt are fixed-rate notes. The company also boasts a consistently robust net cash position, in which management intends to deploy towards additional growth without having to incur incremental capital costs ahead of interest rate increases. This is expected to further cement investors’ confidence in the Apple stock, as they continue their “flight to quality” amidst fear of broader market pressure from rising interest rates.</p>\n<p>The valuation analysis also assumes an exit multiple of 19.8x, which is consistent with current market expectations on Apple’s growth trajectory over the forecasted period. The applied exit multiple assumption could even improve further within the next 12 months, considering the impending launch of new product segments like AR/VR devices and autonomous vehicles, and offset any potential impacts from the upcoming increases to interest rates.</p>\n<p><i>i. Base Case Valuation Analysis:</i></p>\n<p><img src=\"https://static.tigerbbs.com/81f992ef8b2b59ea879f69a7b1e7ad52\" tg-width=\"640\" tg-height=\"300\" width=\"100%\" height=\"auto\"></p>\n<p><i>ii. Sensitivity Analysis:</i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/da8b21dae04fd263929ab26bd8d83907\" tg-width=\"640\" tg-height=\"337\" width=\"100%\" height=\"auto\"><span>Source: Author, with data from our internal valuation analysis.</span></p>\n<p><b>Conclusion</b></p>\n<p>Based on the foregoing analysis, the anticipated addition of 175 to 200 basis points to the current near-zero Federal Fund Rate over the next two years is not expected to cause material adverse impacts to Apple’s performance from both a fundamental and valuation perspective. Robust global demand for Apple products and services, paired with new innovations are expected to further bolster the company’s fundamental growth prospects. This would accordingly bring additional improvements to Apple’s balance sheet, and further strengthen its position against downward valuation pressures from broader macro headwinds. In fact, increasing demand for quality growth stocks to counter risks resulting from the impending rate hikes might even fuel Apple’s valuation growth momentum. On these considerations, Apple remains one of the best-performing tech stocks to own given its robust uptrend to $3 trillion in the near-term despite impending rate hikes.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: The Strongest Shield Against Rate Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: The Strongest Shield Against Rate Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 10:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4475887-apple-stock-aapl-strongest-shield-against-rate-hikes><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nWith inflation running its hottest course in 40 years, the Federal Reserve has decided to accelerate the stimulus tapering schedule and prepare for raising interest rates as early as March.\n...</p>\n\n<a href=\"https://seekingalpha.com/article/4475887-apple-stock-aapl-strongest-shield-against-rate-hikes\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4475887-apple-stock-aapl-strongest-shield-against-rate-hikes","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183475424","content_text":"Summary\n\nWith inflation running its hottest course in 40 years, the Federal Reserve has decided to accelerate the stimulus tapering schedule and prepare for raising interest rates as early as March.\nWhile rate hikes have historically deterred investors from growth stocks due to concerns over eroding valuation prospects, the Apple stock has remained largely resilient.\nApple is expected to realize additional upsides ahead, sustained by robust demand for its existing offerings and new opportunities arising from nascent technologies like AR/VR and autonomous vehicles.\nIts strong net cash position also provides sufficient dry powder to fund additional growth in coming years without incurring additional costs of capital amidst rising interest rates.\nAs such, Apple's bullish thesis remains intact as it approaches a $3 trillion valuation, despite broader market valuation risks ahead.\n\nguvendemir/iStock Unreleased via Getty Images\nAs one of the world’s best performing stocks, Apple(NASDAQ:AAPL) has gained close to 40% this year. The stock, which last peaked at $182.13 not too long ago, is currently less than 7% from being the first U.S. publicly listed company to reach a $3 trillion market value and single-handedly accounts for about 15% of the tech-heavy Nasdaq 100’s performance. Apple’s market value has grown by more than 220x since the late 1990s, buoyed by the company’s continuous ability to capture robust demand for its innovative portfolio of products and services.\nAnd Apple’s strong fundamentals are expected to help the stock defy adverse impacts from the imminent rate hikes beginning next year. With inflation running at its hottest in almost four decades, the Federal Reserve decided Wednesday that it will increase the pace at which it is dialing back on the $120 billion monthly bond repurchasing program from $15 billion per month, which began in November, to $30 billion per month. This would effectively conclude the stimulus program, put in place at the onset of the pandemic, coming March, rather than in July as initially planned. Rate hikes are expected to begin soon after to counter rising price pressures, with Federal Reserve Chair Jerome Powell affirming that the process will only begin after tapering ends and at a gradual pace. The latest dot plot indicates potential for the Federal Fund Rate to lift-off from near-zero beginning early 2022 with three quarter-point increases, plus another three in 2023 and two more in 2024. If materialized, the process would up the funds rate to 2.1% by 2024.\nSource: Bloomberg\nWhile rate hikes typically cause investors to turn risk averse due to concerns over faster erosion of value on future gains and stalled business growth due to rising costs of capital, especially for high-growth stocks, Apple gained close to 3% upon release of the Fed’s update on policy tightening. The stock closed at $179.30 on December 15th, nearing its peak of $182 on Monday. Apple’s rally, along with similar uptrends observed across other mega-cap tech stocks, accordingly drove intra-day gains of 2.4% for the Nasdaq 100 following the Federal Reserve’s update, indicating investors’ preference to park their money in companies with robust growth prospects to counter risks from the impending rate increases.\nWith the coming holiday season a boon for Apple’s December-quarter sales, the stock’s valuation is expected to enter in the $3 trillion territory sooner than expected. Continued robust demand observed across Apple’s entire product line, generous share buy-backs, and additional revenue contributions expected within the foreseeable future resulting from new, cutting-edge products will also be key catalysts to support the company’s persistently strong fundamentals and keep the stock’s valuation above $3 trillion despite the impending rate hikes. Considering recent developments to the broader market and Apple’s growth prospects, we are raising our 12-month price target for the stock to $209.43.\nFY 2021 Overview and Recap of Fundamental Prospects\nFiscal 2021 was a big year for Apple. The company’s revenues for the year grew 33% from fiscal 2020 to $366 billion, despite on-and-off store closures resulting from recurring coronavirus outbreaks and supply chain constraints that have led to more than $9 billion in lost sales. Every product and service segment achieved record-setting revenues with more than 20% growth from previous year results. Much of the year’s success were attributable to a series of new product launches and feature upgrades. The most notable of which included the 5G-enabled family of iPhone 12s and iPhone 13s, as well as the M1-powered MacBook Pro and iPad Pro.\nKey Developments in Products\niPhone sales grew by 39% this year, the most amongst other segments, and drove more than half of Apple’s fiscal 2021 revenues. The results were a stark contrast to last year’s slump in demand for the mobile device when consumers braced for pandemic-driven economic uncertainties. iPhone sales are expected to remain robust in coming years as global 5G device upgrades continue to gather pace. The likely launch of a more affordable 5G-enabled iPhone SE in 2022 is also expected to further Apple’s market share gains by attracting switchers from “more than a billion non-premium Android users”, and drive the active installed base to another all-time high. The anticipated momentum is further corroborated by iPhone sales patterns observed in recent quarters following the launch of 5G-enabled iPhone 12s and iPhone 13s, where the number of upgraders and switchers grew by strong double digits. Apple’s strong ties with cell-phone carriers is also expected to drive meaningful iPhone sales contributions in coming years. Reputable wireless carriers in the U.S. like Verizon and AT&T have already been keen on promoting the sale of 5G-enabled devices like the iPhone 12 and iPhone 13 to encourage migration to the 5G network that they have spent billions of dollars on building across the nation. Telecom companies around the world are expected to spend more than $700 billion over the next five years on building-out the 5G network, underscoring significant additional growth opportunities ahead for the iPhone segment as carriers push for the strongest multiyear upgrade cycle in a decade to recoup their investments.\nMac and iPad sales also grew significantly in fiscal 2021, reaching record revenues of $35.2 billion and $31.9 billion, respectively. Following the introduction of the all-new M1-powered iMac earlier this year, Apple also unveiled the reimagined M1-Pro / M1-Max powered MacBook Pro in October. The custom M1 processors made the newest MacBook “better than any Intel-based device for nearly every productivity use case outside of gaming”. This accordingly drove incredible demand for the portable workstation from a diverse group of consumers, ranging from professional creators and photographers to corporate users and students. The company is estimated to have shipped over 3.2 million units of Mac products during the September quarter, which drove record-setting revenues for the segment, while boosting its rank in global PC sales to fourth place amongst other vendors. The introduction of M1-processors in Apple’s computing products also bolstered its position in capitalizing on the surge in global demand for PCs and multi-purpose tablets by allowing the company to build devices with innovative features that can be seamlessly integrated across its ecosystem of peripheral accessories and services to draw adjacent revenues. With accelerated adoption of hybrid work and study arrangements in the post-pandemic era, global demand for portable workstations like PCs and multi-purpose tablets are expected to remain elevated in coming years – the sectors are expected to grow into a $224.3 billion and$600 billion market, respectively, by 2025, which makes favorable trends for Apple’s Mac and iPad segments.\nRecent speculations on Apple’s intentions to strengthen its in-house chip development capacity will likely further the advancement of its technologies offered in coming years and draw additional demand to its products. The company is currently looking for engineers to build-out its capacity in the development of “wireless radios, radio-frequency integrated circuits, and a wireless system-on-chip (“SoC”)”, as well as “semiconductors for connecting Bluetooth and Wi-Fi”. These developments are expected to further enhance seamless integration across Apple’s devices and increase stickiness to its ecosystem of product and service offerings, making its chip unit one of the company’s “most prized assets”.\nKey Developments in Services\nOn the services front, a strong subscriber base had enabled the segment to hit record-setting revenues of more than $68.4 billion in fiscal 2021, up 27% from the prior year. To date, Apple has garnered more than 745 million paid subscribers across its high-margin service offerings, representing a five-fold increase over the last five years. Apple’s increasing push for a subscription-based business model across its wide variety of service platforms, ranging from Apple Music to iCloud storage solutions, paired with attractive new offerings that address key consumer trends in recent years have been a key driver to the company’s fast-expanding margins. New exciting add-on features introduced for existing service platforms include Spatial Audio and Lossless Audiofor Apple Music and the Apple Music Voice Plan. The new subscription-based offerings are expected to further Apple’s reach to adjacent opportunities stemming from increasing global usage of smartphones, laptops and other advanced home electronic products – for instance, the global music streaming market is expected to expand at a CAGR of 16% towards a projected value of $61 billion over the next five years, underscoring significant growth headroom for Apple Music. And Apple’s latest introduction of the Apple One bundle is expected to be a key contributor to furthering service segment sales in coming years by attracting new users to pay for subscription services that they otherwise would not have had it not been for the bundle discounts.\nContinued growth in market demand for mobile applications will also be a boon to Apple’s fast-growing services segment. The global market for mobile applications is expected to grow at a CAGR of 18.4% and reach a market value of more than $400 billion over the next five years. With AAPL hosting one of the largest and most used app stores in the world, it would be reasonable to assume that related revenues would grow at a similar pace. Despite mounting global regulatory scrutiny over Apple’s alleged antitrust violations with its App Store – the most notable of which stemming from an ongoing legal battle with Epic Games– the company’s continued focus on ensuring user privacy, security, and ease of transactions might have saved the day. According to a survey of 4,000 Apple product users performed by Morgan Stanley across the U.S. and China, most have indicated loyalty to Apple’s App store due to the “value of security, privacy and ease of transactions” provided, despite developers pushing for rights to transact outside of Apple’s ecosystem. Apple’s recent success in delaying App Store changes ordered by U.S. District Judge Yvonne Gonzalez Rogers in September as part of a year-long lawsuit brought against by Epic Games is another sign of the App Store’s continued strength. The company has argued that the court-mandated order to allow App Store users to “buy directly from developers on the web” would be a threat to the security of their privacy.\nCurrently, developers are fighting for their rights to have app users transact outside of Apple’s ecosystem, which charges developers a hefty commission fee of up to 30% on all purchases. As Apple continues with its appeal of the ruling, the ultimate court decision on whether App Store changes would need to be implemented could take at least another year. But even with an unfavorable ruling, where Apple would have to allow developers to redirect users to payments outside of its ecosystem and/or lower its in-app purchase commission rate, App Store revenues are only expected to decrease by at most $4 billion per year which will not place a material impact on its valuation prospects. The actual quantified impact might even be less than what the market has forecasted, considering the value that App Store users have ascribed to the level of security and convenience that Apple has offered through the platform.\nKey Catalysts Ahead\nApple is undoubtedly a key gateway to bringing emerging technologies to the mainstream due to its massive installed base of devices and related service platform users. And because of this, the highly anticipated launch of cutting-edge products like AR/VR headsets and autonomous vehicles in coming years will likely catapult the stock to new heights. The pioneer of disruptive consumer electronics and devices is expected to launch a VR headset and AR glasses by early 2023, a nascent technology that has been picking up steam in recent months with increasing talks of the metaverse. Similar to most VR headsets already available in the market, Apple’s will feature a 3D display to enable an immersive environment for a variety of activities from gaming to communicating. The differentiating factor will be the company’s plans to implement best-in-class graphics chips in the device to facilitate ultra-high-resolution displays. The impending VR headset will ultimately lay the foundation for its AR glasses, which Apple expects to be the “larger opportunity”.\nOver the next five years, opportunities pertaining to the metaverse are expected to blossom into an $800 billion market. Related software and service sales are expected to drive more than 70% of the projected addressable market, while the remainder will likely be driven by hardware sales. This makes strong tailwinds for Apple, which does not only stand to capitalize on growing metaverse opportunities through the sale of its impending AR/VR headset, but also adjacent revenues pertaining to the usage of related apps, software and service platforms.\nSpeculations on Apple’s ongoing development of a self-driving electric car is also expected to materialize into meaningful upsides for the stock within the foreseeable future. The company is now planning to launch the new product category by 2025, at which time the global autonomous vehicle market is expected to reach a value of more than $200 billion. The eventual car will likely feature homages to its existing product portfolio, like an “iPad-like touch screen” infotainment system. And on the technology front, Apple is believed to have completed the development of a custom silicon for powering the vehicle’s autonomous driving capabilities. The newest chips will soon be implemented into its existing fleet of retrofitted SUVs for testing in California according to the state’s DMV, a sign that the impending launch is near.\nWhile Apple’s current market value may already be reflective of “consistent material revenue contributions from new products and services over time”, additional upsides from the above-mentioned new product category launches are still missing. But this will likely change within the next 12 months as the impending launch of an Apple AR/VR device draws near. Near-term projections on early AR/VR device sales are expected to boost Apple’s valuation by at least $150 billion. And over time when metaverse trends continue to gain mainstream traction, Apple is expected to generate more than $200 billion in annual revenues from the AR/VR segment, which could add another 15% on top of its current market value.\nValuation Prospects and Potential Impacts from the Impending Rate Increases\nAdjusting our most recent forecast for Apple’s fiscal 2021 year-end results and December-quarter guidance, our base case projection estimates total net sales of $439.3 billion by the end of fiscal 2022, with further growth towards $668.5 billion by fiscal 2026. The growth assumptions applied across segment revenues in our forecast remains largely unchanged from our most recent analysis on the stock, with additional consideration for management’s near-term outlook on supply constraint impacts and the impending rate hikes. Specifically, lost revenues of $9 billion (i.e. approximately $3 billion during June-quarter and $6 billion during September-quarter) attributable to industry-wide chip shortages and pandemic-driven manufacturing delays during the second half of fiscal 2021 is expected to worsen into the first half of fiscal 2022. While there have been observed improvements to supply chain challenges, continuously robust demand for Apple products is what will drive a higher volume of lost sales in coming quarters. Nonetheless, Apple remains well-positioned for strong fundamentals ahead, which will help to alleviate some of investors’ concerns on valuation due to impending rate hikes.\n\ni. Base Case Financial Projections:\nSource: Author, with data from our internal financial forecast (Apple_-_Forecasted_Financial_Information.pdf). Please refer here for further detail on material growth assumptions applied.\nDrawing on the above considerations, our 12-month price target for the Apple stock has been revised to $209.43. This represents upside potential of more than 22% based on the last traded price of $171.14 on December 17th.\nSource: Author, with data from our internal valuation analysis.\nThe revised price target is derived using a discounted cash flow (“DCF”) analysis over a ten-year discrete period in conjunction with the financial projections updated for Apple’s recent developments as analyzed in earlier sections. Similar to our original valuation analysis, we have applied a WACC of 8% to discount Apple’s projected free cash flows. The discount function is reflective of the company’s risk profile, taking into consideration its current capital structure and strong balance sheet. Apple’s cost of capital for growth is not expected to change significantly as a result of the impending rate hikes, considering a large portion of its existing debt are fixed-rate notes. The company also boasts a consistently robust net cash position, in which management intends to deploy towards additional growth without having to incur incremental capital costs ahead of interest rate increases. This is expected to further cement investors’ confidence in the Apple stock, as they continue their “flight to quality” amidst fear of broader market pressure from rising interest rates.\nThe valuation analysis also assumes an exit multiple of 19.8x, which is consistent with current market expectations on Apple’s growth trajectory over the forecasted period. The applied exit multiple assumption could even improve further within the next 12 months, considering the impending launch of new product segments like AR/VR devices and autonomous vehicles, and offset any potential impacts from the upcoming increases to interest rates.\ni. Base Case Valuation Analysis:\n\nii. Sensitivity Analysis:\nSource: Author, with data from our internal valuation analysis.\nConclusion\nBased on the foregoing analysis, the anticipated addition of 175 to 200 basis points to the current near-zero Federal Fund Rate over the next two years is not expected to cause material adverse impacts to Apple’s performance from both a fundamental and valuation perspective. Robust global demand for Apple products and services, paired with new innovations are expected to further bolster the company’s fundamental growth prospects. This would accordingly bring additional improvements to Apple’s balance sheet, and further strengthen its position against downward valuation pressures from broader macro headwinds. In fact, increasing demand for quality growth stocks to counter risks resulting from the impending rate hikes might even fuel Apple’s valuation growth momentum. On these considerations, Apple remains one of the best-performing tech stocks to own given its robust uptrend to $3 trillion in the near-term despite impending rate hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699450200,"gmtCreate":1639880412144,"gmtModify":1639880412316,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699450200","repostId":"1138605449","repostType":4,"repost":{"id":"1138605449","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639746084,"share":"https://www.laohu8.com/m/news/1138605449?lang=&edition=full","pubTime":"2021-12-17 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1138605449","media":"Tiger Newspress","summary":"U.S. Stock futures headed for a lower open Friday morning after a rout in technology stocks during T","content":"<p>U.S.&nbsp;Stock futures headed for a lower open Friday morning after a rout in technology stocks during Thursday's regular trading day, as investors turned away from growth stocks in anticipation of tighter monetary policy next year.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 117 points, or 0.33%, S&amp;P 500 e-minis were down 24 points, or 0.52%, and Nasdaq 100 e-minis were down 153.5 points, or 0.97%.<img src=\"https://static.tigerbbs.com/120d112226a9ec4591babf844729ca58\" tg-width=\"1080\" tg-height=\"376\" width=\"100%\" height=\"auto\">Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fed&nbsp;could hike interest rates three times next year.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a></b> – The parent of Olive Garden, Longhorn Steakhouse and other restaurant chains beat estimates by 5 cents with quarterly earnings of $1.48 per share and revenue that also topped forecasts. Same-restaurant sales jumped 34.4%, higher than the 32.6% consensus estimate compiled by StreetAccount, and Darden issued an upbeat forecast. Separately, Darden announced that CEO Eugene Lee will retire in May 2022, to be replaced by current President and Chief Operating Officer Ricardo Cardenas. Darden fell 5% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/WGO\">Winnebago</a></b> – The recreational vehicle maker added 3.4% in premarket trading after a sizable bottom-line beat for its fiscal first quarter. Winnebago earned $3.51 per share, compared with the consensus estimate of $2.26 and revenue that also came in above analyst forecasts.</p>\n<p><b><a href=\"https://laohu8.com/S/FDX\">FedEx</a></b> – The delivery service’s shares rallied 5.9% in the premarket after beating estimates on the top and bottom lines for its latest quarter. FedEx earned an adjusted $4.83 per share, beating the $4.28 consensus estimate, with higher shipping rates helping to make up for increased expenses.</p>\n<p><b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker lost $1.23 billion for the third quarter stemming from expenses to begin production of its electric pickup truck. It was Rivian’s first quarterly report since going public, and revenue was $1 million from its first deliveries. The stock tumbled 7.9% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/EPAY\">Bottomline</a></b> – Bottomline shares soared 15.1% in the premarket after the fintech company agreed to be acquired by private equity firm Thoma Bravo for $57 per share in cash, or $2.6 billion.</p>\n<p><b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> – The healthcare information-technology company’s stock soared 18.9% in premarket trading after the Wall Street Journal reported that&nbsp;Oracle(ORCL) was in talks to buy Cerner in a potential $30 billion deal. Oracle fell 4.6%.</p>\n<p><b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> – <b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> shares fell 2.1% in the premarket after the CDC recommended that adults receive the&nbsp;Pfizer(PFE) or&nbsp;Moderna(MRNA) Covid-19 vaccines rather than the J&amp;J shot. The CDC cited new data showing higher levels of a blood clotting condition than previously thought, although that condition remains rare.</p>\n<p><b><a href=\"https://laohu8.com/S/AFRM\">Affirm Holdings, Inc.</a></b> – The “buy now pay later” company’s stock fell 2.3% in the premarket after the Consumer Financial Protection Bureau said it was launching an inquiry into firms that offer such plans.</p>\n<p><b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> – The drug maker’s stock rose 1.3% in premarket action on a Financial Times report that the European Medicines Agency may approve its Covid-19 vaccine for emergency use as early as next week.</p>\n<p><b><a href=\"https://laohu8.com/S/X\">U.S. Steel</a></b> – The steel maker’s stock slid 4.4% in the premarket after the company issued lower-than-expected current-quarter guidance, with higher expenses and cautious customer buying patterns offsetting improved steel pricing.</p>\n<p><b><a href=\"https://laohu8.com/S/SCS\">Steelcase</a></b> – The office furniture maker reported lower-than-expected profit and revenue for the third quarter, with Steelcase saying its results have been impacted by supply chain issues and higher costs. Steelcase fell 4.4% in premarket trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.&nbsp;Stock futures headed for a lower open Friday morning after a rout in technology stocks during Thursday's regular trading day, as investors turned away from growth stocks in anticipation of tighter monetary policy next year.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 117 points, or 0.33%, S&amp;P 500 e-minis were down 24 points, or 0.52%, and Nasdaq 100 e-minis were down 153.5 points, or 0.97%.<img src=\"https://static.tigerbbs.com/120d112226a9ec4591babf844729ca58\" tg-width=\"1080\" tg-height=\"376\" width=\"100%\" height=\"auto\">Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fed&nbsp;could hike interest rates three times next year.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a></b> – The parent of Olive Garden, Longhorn Steakhouse and other restaurant chains beat estimates by 5 cents with quarterly earnings of $1.48 per share and revenue that also topped forecasts. Same-restaurant sales jumped 34.4%, higher than the 32.6% consensus estimate compiled by StreetAccount, and Darden issued an upbeat forecast. Separately, Darden announced that CEO Eugene Lee will retire in May 2022, to be replaced by current President and Chief Operating Officer Ricardo Cardenas. Darden fell 5% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/WGO\">Winnebago</a></b> – The recreational vehicle maker added 3.4% in premarket trading after a sizable bottom-line beat for its fiscal first quarter. Winnebago earned $3.51 per share, compared with the consensus estimate of $2.26 and revenue that also came in above analyst forecasts.</p>\n<p><b><a href=\"https://laohu8.com/S/FDX\">FedEx</a></b> – The delivery service’s shares rallied 5.9% in the premarket after beating estimates on the top and bottom lines for its latest quarter. FedEx earned an adjusted $4.83 per share, beating the $4.28 consensus estimate, with higher shipping rates helping to make up for increased expenses.</p>\n<p><b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker lost $1.23 billion for the third quarter stemming from expenses to begin production of its electric pickup truck. It was Rivian’s first quarterly report since going public, and revenue was $1 million from its first deliveries. The stock tumbled 7.9% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/EPAY\">Bottomline</a></b> – Bottomline shares soared 15.1% in the premarket after the fintech company agreed to be acquired by private equity firm Thoma Bravo for $57 per share in cash, or $2.6 billion.</p>\n<p><b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> – The healthcare information-technology company’s stock soared 18.9% in premarket trading after the Wall Street Journal reported that&nbsp;Oracle(ORCL) was in talks to buy Cerner in a potential $30 billion deal. Oracle fell 4.6%.</p>\n<p><b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> – <b><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a></b> shares fell 2.1% in the premarket after the CDC recommended that adults receive the&nbsp;Pfizer(PFE) or&nbsp;Moderna(MRNA) Covid-19 vaccines rather than the J&amp;J shot. The CDC cited new data showing higher levels of a blood clotting condition than previously thought, although that condition remains rare.</p>\n<p><b><a href=\"https://laohu8.com/S/AFRM\">Affirm Holdings, Inc.</a></b> – The “buy now pay later” company’s stock fell 2.3% in the premarket after the Consumer Financial Protection Bureau said it was launching an inquiry into firms that offer such plans.</p>\n<p><b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> – The drug maker’s stock rose 1.3% in premarket action on a Financial Times report that the European Medicines Agency may approve its Covid-19 vaccine for emergency use as early as next week.</p>\n<p><b><a href=\"https://laohu8.com/S/X\">U.S. Steel</a></b> – The steel maker’s stock slid 4.4% in the premarket after the company issued lower-than-expected current-quarter guidance, with higher expenses and cautious customer buying patterns offsetting improved steel pricing.</p>\n<p><b><a href=\"https://laohu8.com/S/SCS\">Steelcase</a></b> – The office furniture maker reported lower-than-expected profit and revenue for the third quarter, with Steelcase saying its results have been impacted by supply chain issues and higher costs. Steelcase fell 4.4% in premarket trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138605449","content_text":"U.S. Stock futures headed for a lower open Friday morning after a rout in technology stocks during Thursday's regular trading day, as investors turned away from growth stocks in anticipation of tighter monetary policy next year.\nAt 8:00 a.m. ET, Dow e-minis were down 117 points, or 0.33%, S&P 500 e-minis were down 24 points, or 0.52%, and Nasdaq 100 e-minis were down 153.5 points, or 0.97%.Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fed could hike interest rates three times next year.\nStocks making the biggest moves premarket: \nDarden Restaurants – The parent of Olive Garden, Longhorn Steakhouse and other restaurant chains beat estimates by 5 cents with quarterly earnings of $1.48 per share and revenue that also topped forecasts. Same-restaurant sales jumped 34.4%, higher than the 32.6% consensus estimate compiled by StreetAccount, and Darden issued an upbeat forecast. Separately, Darden announced that CEO Eugene Lee will retire in May 2022, to be replaced by current President and Chief Operating Officer Ricardo Cardenas. Darden fell 5% in the premarket.\nWinnebago – The recreational vehicle maker added 3.4% in premarket trading after a sizable bottom-line beat for its fiscal first quarter. Winnebago earned $3.51 per share, compared with the consensus estimate of $2.26 and revenue that also came in above analyst forecasts.\nFedEx – The delivery service’s shares rallied 5.9% in the premarket after beating estimates on the top and bottom lines for its latest quarter. FedEx earned an adjusted $4.83 per share, beating the $4.28 consensus estimate, with higher shipping rates helping to make up for increased expenses.\nRivian Automotive, Inc. – The electric vehicle maker lost $1.23 billion for the third quarter stemming from expenses to begin production of its electric pickup truck. It was Rivian’s first quarterly report since going public, and revenue was $1 million from its first deliveries. The stock tumbled 7.9% in premarket trading.\nBottomline – Bottomline shares soared 15.1% in the premarket after the fintech company agreed to be acquired by private equity firm Thoma Bravo for $57 per share in cash, or $2.6 billion.\nCerner – The healthcare information-technology company’s stock soared 18.9% in premarket trading after the Wall Street Journal reported that Oracle(ORCL) was in talks to buy Cerner in a potential $30 billion deal. Oracle fell 4.6%.\nJohnson & Johnson – Johnson & Johnson shares fell 2.1% in the premarket after the CDC recommended that adults receive the Pfizer(PFE) or Moderna(MRNA) Covid-19 vaccines rather than the J&J shot. The CDC cited new data showing higher levels of a blood clotting condition than previously thought, although that condition remains rare.\nAffirm Holdings, Inc. – The “buy now pay later” company’s stock fell 2.3% in the premarket after the Consumer Financial Protection Bureau said it was launching an inquiry into firms that offer such plans.\nNovavax – The drug maker’s stock rose 1.3% in premarket action on a Financial Times report that the European Medicines Agency may approve its Covid-19 vaccine for emergency use as early as next week.\nU.S. Steel – The steel maker’s stock slid 4.4% in the premarket after the company issued lower-than-expected current-quarter guidance, with higher expenses and cautious customer buying patterns offsetting improved steel pricing.\nSteelcase – The office furniture maker reported lower-than-expected profit and revenue for the third quarter, with Steelcase saying its results have been impacted by supply chain issues and higher costs. Steelcase fell 4.4% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699450988,"gmtCreate":1639880353337,"gmtModify":1639880353512,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699450988","repostId":"2192754259","repostType":4,"repost":{"id":"2192754259","pubTimestamp":1639811460,"share":"https://www.laohu8.com/m/news/2192754259?lang=&edition=full","pubTime":"2021-12-18 15:11","market":"us","language":"en","title":"Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2192754259","media":"Motley Fool","summary":"Three names you know are trading within 10% of their 52-week lows. They deserve better.","content":"<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.</p>\n<p><b>Disney</b>&nbsp;(NYSE:DIS),<b> <a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>&nbsp;(NYSE:TWTR), and <b>Toast </b>(NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.</p>\n<h4><a href=\"https://laohu8.com/S/DIS\">Disney</a></h4>\n<p>Disney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.</p>\n<p>It's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.</p>\n<p>Disney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.</p>\n<p><b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b></p>\n<p>Another shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.</p>\n<p>The platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.</p>\n<h4><a href=\"https://laohu8.com/S/TOST\">Toast</a></h4>\n<p>Running a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.</p>\n<p>Toast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.</p>\n<p>Despite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 15:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4077":"互动媒体与服务","BK4550":"红杉资本持仓","BK4516":"特朗普概念","BK4561":"索罗斯持仓","BK4508":"社交媒体","BK4554":"元宇宙及AR概念","BK4106":"数据处理与外包服务","BK4532":"文艺复兴科技持仓","TWTR":"Twitter","DIS":"迪士尼","TOST":"Toast, Inc.","BK4524":"宅经济概念","BK4108":"电影和娱乐","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192754259","content_text":"The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.\nDisney (NYSE:DIS), Twitter (NYSE:TWTR), and Toast (NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.\nDisney\nDisney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.\nIt's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.\nDisney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.\nTwitter\nAnother shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.\nThe platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.\nToast\nRunning a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.\nToast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.\nDespite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1070,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699658940,"gmtCreate":1639795431583,"gmtModify":1639795431869,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Thanks for sharing 👍","listText":"Thanks for sharing 👍","text":"Thanks for sharing 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699658940","repostId":"2192497854","repostType":4,"repost":{"id":"2192497854","pubTimestamp":1639746681,"share":"https://www.laohu8.com/m/news/2192497854?lang=&edition=full","pubTime":"2021-12-17 21:11","market":"us","language":"en","title":"3 Warren Buffett Stocks I Like Heading Into 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192497854","media":"Motley Fool","summary":"Three of Buffett's largest holdings look strong heading into 2022.","content":"<p>Warren Buffett and his company&nbsp;<b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) are well known for their stock-picking abilities that have been proven over many decades. For this prowess, along with Berkshire's success in the other businesses the conglomerate operates in, the stock has consistently been a winner.</p>\n<p>Between 1965 and 2020, Berkshire's stock has generated compounded annual gains of 20%, compared to the <b>S&amp;P 500</b>'s compounded annual gain of 10.2%, including dividends, over the same timeframe. It's for this very reason that investors watch Buffett and Berkshire's stock picks so closely. Here are three Buffett stocks I like heading into 2022.</p>\n<h2>1. Bank of America</h2>\n<p>America's second-largest bank by assets,&nbsp;<b>Bank of America</b> (NYSE:BAC), also happens to be the second-largest position in Buffett and Berkshire's equities portfolio. Buffett first got in on Bank of America coming out of the Great Recession and currently owns more than 1 billion shares worth nearly $45.8 billion. Early in the pandemic in the middle of 2020, Buffett took advantage of the beaten-down bank sector to plow another $2 billion into Bank of America and now owns nearly 12% of the financial institution's outstanding shares.</p>\n<p>Shares of Bank of America have climbed more than 47% this year and are up more than double from pandemic lows. While the valuation has gotten high, I like Bank of America because it is well-positioned to deal with higher inflation, higher interest rates, and more difficult market conditions that could be seen next year. Higher interest rates benefit Bank of America tremendously because the yields on many of the loans at the bank will increase along with the rate hikes. The consumer is currently in great shape. Since banking is linked to the overall economy and gross domestic product in the U.S. is expected to grow about 4% next year, I think the bank is going to have a good year.</p>\n<h2>2. American Express</h2>\n<p>Berkshire owns more than 151 million shares of the credit card company <b>American Express</b> (NYSE:AXP) for a total value of roughly $24.7 billion, making it the third-largest holding in Berkshire's portfolio. American Express has also had a nice year with the stock price up more than 38%.</p>\n<p>There are two main reasons I like American Express heading into 2022. For one, because the consumer has been so healthy, Americans have been paying off their credit card bills and haven't had as much need to take on debt. As money and benefits from previous stimulus bills run down, that won't always be the case. At the beginning of December, <i>The Wall Street Journal</i> reported that credit card applications had recently hit a pandemic high.</p>\n<p>American Express is also big in the travel, airlines, and lodging businesses, so the more the world continues to recover from the pandemic and COVID-19, the more its business will benefit. Some of those travel-related sectors still aren't fully back yet, especially when you think about international travel.</p>\n<h2>3. U.S. Bancorp</h2>\n<p>Buffett and Berkshire own more than 144 million shares valued at nearly $8.3 billion of the large regional bank <b>U.S. Bancorp </b>(NYSE:USB). The bank is a high-performing commercial bank. It also runs a unique payments business that includes retail credit, debit, prepaid cards, global merchant acquiring, and corporate payment solutions in sectors such as aviation, fleet, transportation, and travel.</p>\n<p>Because the payments business operates in these sectors, the segment could still recover further in 2022 as the world rebounds from COVID-19. Additionally, management is very focused on further integrating the payments and commercial banking businesses because 72% of the bank's business banking customers still don't have a payments product, and half of U.S. Bancorp's payments customers don't have a banking product.</p>\n<p>There's a lot of opportunity for cross-selling. U.S. Bancorp also recently announced its intention to acquire the U.S. banking division of <b>Mitsubishi UFJ Financial Group</b>. This deal will give U.S. Bancorp an additional 190,000 business banking customers and more scale in California, both things that are in line with U.S. Bancorp's current strategy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I Like Heading Into 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I Like Heading Into 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/3-warren-buffett-stocks-i-like-heading-into-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett and his company Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) are well known for their stock-picking abilities that have been proven over many decades. For this prowess, along with ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/3-warren-buffett-stocks-i-like-heading-into-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4176":"多领域控股","BK4166":"消费信贷","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4504":"桥水持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BRK.B":"伯克希尔B","USB":"美国合众银行","BK4553":"喜马拉雅资本持仓","AXP":"美国运通","BAC":"美国银行","BK4207":"综合性银行","BRK.A":"伯克希尔"},"source_url":"https://www.fool.com/investing/2021/12/17/3-warren-buffett-stocks-i-like-heading-into-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192497854","content_text":"Warren Buffett and his company Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) are well known for their stock-picking abilities that have been proven over many decades. For this prowess, along with Berkshire's success in the other businesses the conglomerate operates in, the stock has consistently been a winner.\nBetween 1965 and 2020, Berkshire's stock has generated compounded annual gains of 20%, compared to the S&P 500's compounded annual gain of 10.2%, including dividends, over the same timeframe. It's for this very reason that investors watch Buffett and Berkshire's stock picks so closely. Here are three Buffett stocks I like heading into 2022.\n1. Bank of America\nAmerica's second-largest bank by assets, Bank of America (NYSE:BAC), also happens to be the second-largest position in Buffett and Berkshire's equities portfolio. Buffett first got in on Bank of America coming out of the Great Recession and currently owns more than 1 billion shares worth nearly $45.8 billion. Early in the pandemic in the middle of 2020, Buffett took advantage of the beaten-down bank sector to plow another $2 billion into Bank of America and now owns nearly 12% of the financial institution's outstanding shares.\nShares of Bank of America have climbed more than 47% this year and are up more than double from pandemic lows. While the valuation has gotten high, I like Bank of America because it is well-positioned to deal with higher inflation, higher interest rates, and more difficult market conditions that could be seen next year. Higher interest rates benefit Bank of America tremendously because the yields on many of the loans at the bank will increase along with the rate hikes. The consumer is currently in great shape. Since banking is linked to the overall economy and gross domestic product in the U.S. is expected to grow about 4% next year, I think the bank is going to have a good year.\n2. American Express\nBerkshire owns more than 151 million shares of the credit card company American Express (NYSE:AXP) for a total value of roughly $24.7 billion, making it the third-largest holding in Berkshire's portfolio. American Express has also had a nice year with the stock price up more than 38%.\nThere are two main reasons I like American Express heading into 2022. For one, because the consumer has been so healthy, Americans have been paying off their credit card bills and haven't had as much need to take on debt. As money and benefits from previous stimulus bills run down, that won't always be the case. At the beginning of December, The Wall Street Journal reported that credit card applications had recently hit a pandemic high.\nAmerican Express is also big in the travel, airlines, and lodging businesses, so the more the world continues to recover from the pandemic and COVID-19, the more its business will benefit. Some of those travel-related sectors still aren't fully back yet, especially when you think about international travel.\n3. U.S. Bancorp\nBuffett and Berkshire own more than 144 million shares valued at nearly $8.3 billion of the large regional bank U.S. Bancorp (NYSE:USB). The bank is a high-performing commercial bank. It also runs a unique payments business that includes retail credit, debit, prepaid cards, global merchant acquiring, and corporate payment solutions in sectors such as aviation, fleet, transportation, and travel.\nBecause the payments business operates in these sectors, the segment could still recover further in 2022 as the world rebounds from COVID-19. Additionally, management is very focused on further integrating the payments and commercial banking businesses because 72% of the bank's business banking customers still don't have a payments product, and half of U.S. Bancorp's payments customers don't have a banking product.\nThere's a lot of opportunity for cross-selling. U.S. Bancorp also recently announced its intention to acquire the U.S. banking division of Mitsubishi UFJ Financial Group. This deal will give U.S. Bancorp an additional 190,000 business banking customers and more scale in California, both things that are in line with U.S. Bancorp's current strategy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690982240,"gmtCreate":1639621867350,"gmtModify":1639621867547,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Great 👍","listText":"Great 👍","text":"Great 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690982240","repostId":"1156446659","repostType":2,"repost":{"id":"1156446659","pubTimestamp":1639540344,"share":"https://www.laohu8.com/m/news/1156446659?lang=&edition=full","pubTime":"2021-12-15 11:52","market":"us","language":"en","title":"Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap","url":"https://stock-news.laohu8.com/highlight/detail?id=1156446659","media":"Business Insider","summary":"Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Frid","content":"<ul>\n <li><b>Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.</b></li>\n <li><b>That makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $649 billion market capitalization.</b></li>\n <li><b>Warren Buffett started to build Berkshire's position in Apple in 2016 and added to it up until mid-2018.</b></li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4348b5dc216a2be5e154d22e356336b9\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>SCOTT MORGAN/REUTERS</span></p>\n<p>Warren Buffett is known for concentrating his investments to build generational wealth, and&nbsp;Berkshire Hathaway's&nbsp;stake in&nbsp;Apple&nbsp;is no better example of that investment practice.</p>\n<p>Berkshire's 887.1 million shares in the iPhone maker swelled to a record value of $159 billion on Friday, a 342% increase from its&nbsp;original cost basis of about $36 billion.That means Apple is now worth more than half of Berkshire's $293 billion equity portfolio, based on data from its third-quarter 13F filing.</p>\n<p>And assuming Berkshire hasn't trimmed its Apple position since September 30, the equity stake now represents about a quarter of Berkshire Hathaway's $649 billion market capitalization.</p>\n<p>What also makes Buffett's concentration in Apple notable is that it didn't take&nbsp;decades to compound&nbsp;like most successful investments managed by Buffett. Instead, it's only been five years since Berkshire began to build its stake in Apple.</p>\n<p>The conglomerate first purchased Apple shares in 2016 and continued buying them until mid-2018, when the position topped 1 billion shares after adjusting for a 4-for-1 stock split in 2020. Buffett has&nbsp;trimmed Berkshire's position in Apple&nbsp;by about 12% since initially building the stake.</p>\n<p>Barring any changes since the most recent 13F filing, Berkshire's stock portfolio would be up 13.9% quarter-to-date, according to&nbsp;an analysis by Bespoke.Much of that gain has been driven by Apple's quarter-to-date gain of more than 20%.</p>\n<p>Year-to-date, Apple is up 31%, compared to Berkshire Hathaway's return of 26%. Apple's stock price was less than&nbsp;$1.00 away from hitting a $3 trillion valuation on Monday.</p>\n<p>Berkshire's three largest positions after Apple are&nbsp;Bank of America,American Express, and&nbsp;Coca-Cola, which make up a combined 30% of the equity portfolio's value. And Berkshire is still sitting on about $150 billion in cash that it has yet to put to work.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 11:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12><strong>Business Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.\nThat makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156446659","content_text":"Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.\nThat makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $649 billion market capitalization.\nWarren Buffett started to build Berkshire's position in Apple in 2016 and added to it up until mid-2018.\n\nSCOTT MORGAN/REUTERS\nWarren Buffett is known for concentrating his investments to build generational wealth, and Berkshire Hathaway's stake in Apple is no better example of that investment practice.\nBerkshire's 887.1 million shares in the iPhone maker swelled to a record value of $159 billion on Friday, a 342% increase from its original cost basis of about $36 billion.That means Apple is now worth more than half of Berkshire's $293 billion equity portfolio, based on data from its third-quarter 13F filing.\nAnd assuming Berkshire hasn't trimmed its Apple position since September 30, the equity stake now represents about a quarter of Berkshire Hathaway's $649 billion market capitalization.\nWhat also makes Buffett's concentration in Apple notable is that it didn't take decades to compound like most successful investments managed by Buffett. Instead, it's only been five years since Berkshire began to build its stake in Apple.\nThe conglomerate first purchased Apple shares in 2016 and continued buying them until mid-2018, when the position topped 1 billion shares after adjusting for a 4-for-1 stock split in 2020. Buffett has trimmed Berkshire's position in Apple by about 12% since initially building the stake.\nBarring any changes since the most recent 13F filing, Berkshire's stock portfolio would be up 13.9% quarter-to-date, according to an analysis by Bespoke.Much of that gain has been driven by Apple's quarter-to-date gain of more than 20%.\nYear-to-date, Apple is up 31%, compared to Berkshire Hathaway's return of 26%. Apple's stock price was less than $1.00 away from hitting a $3 trillion valuation on Monday.\nBerkshire's three largest positions after Apple are Bank of America,American Express, and Coca-Cola, which make up a combined 30% of the equity portfolio's value. And Berkshire is still sitting on about $150 billion in cash that it has yet to put to work.","news_type":1},"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690981895,"gmtCreate":1639621577805,"gmtModify":1639621577962,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"🚀🚀","listText":"🚀🚀","text":"🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690981895","repostId":"607772702","repostType":1,"repost":{"id":607772702,"gmtCreate":1639610585070,"gmtModify":1639610585253,"author":{"id":"4094887359325460","authorId":"4094887359325460","name":"AnnieReis","avatar":"https://static.tigerbbs.com/9ac7e5d95e484c74f3326b57fa3c7fc0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094887359325460","authorIdStr":"4094887359325460"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>j继续加油! 😁","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>j继续加油! 😁","text":"$Pfizer(PFE)$j继续加油! 😁","images":[{"img":"https://static.tigerbbs.com/d270f00cc6ddb3feb6800fe6e28210f1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607772702","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607666146,"gmtCreate":1639533974599,"gmtModify":1639533974753,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607666146","repostId":"2191784951","repostType":4,"repost":{"id":"2191784951","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639522244,"share":"https://www.laohu8.com/m/news/2191784951?lang=&edition=full","pubTime":"2021-12-15 06:50","market":"us","language":"en","title":"Wall Street ends down, investors eye inflation and Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=2191784951","media":"Reuters","summary":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads ","content":"<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, investors eye inflation and Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, investors eye inflation and Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","SSO":"两倍做多标普500ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","AAPL":"苹果","BK4559":"巴菲特持仓","COMP":"Compass, Inc.","BK4550":"红杉资本持仓","SPY":"标普500ETF",".DJI":"道琼斯","BK4079":"房地产服务",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","OEX":"标普100","OEF":"标普100指数ETF-iShares","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","BK4539":"次新股","IVV":"标普500指数ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191784951","content_text":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads declines, financials rally\n* Indexes: Dow -0.30%, S&P 500 -0.75%, Nasdaq -1.14%\nDec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.\nThe fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&P 500 index hit an all-time closing high late last week.\nDeclines were led by megacap tech-related stocks, with Salesforce.com, Microsoft Corp, Adobe and Alphabet Inc pulling down the S&P 500 and Nasdaq.\nApple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.\nThe Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&P 500 lost 0.75% to 4,634.09.\nThe Nasdaq Composite dropped 1.14% to 15,237.64.\nData from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.\nAbout two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.\n\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"\nTen of the 11 major S&P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.\nBerkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&P 500 from falling further.\nMany investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.\n\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nInflation\nBeyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"\nPfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.\nVolume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604745561,"gmtCreate":1639450147669,"gmtModify":1639451134970,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604745561","repostId":"1167465214","repostType":4,"repost":{"id":"1167465214","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406352,"share":"https://www.laohu8.com/m/news/1167465214?lang=&edition=full","pubTime":"2021-12-13 22:39","market":"us","language":"en","title":"Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share","url":"https://stock-news.laohu8.com/highlight/detail?id=1167465214","media":"Tiger Newspress","summary":"Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.Pfi","content":"<p>Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.<img src=\"https://static.tigerbbs.com/baca4cde05c414b1c77aa618108489b1\" tg-width=\"774\" tg-height=\"568\" width=\"100%\" height=\"auto\">Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.</p>\n<p>Pfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.</p>\n<p>Arena is developing several treatments for gastroenterology, dermatology, and cardiology. The drug developer's ulcerative colitis treatment candidate, etrasimod, is in a late-stage study.</p>\n<p>Pfizer said it expects to finance the transaction with cash on hand.</p>\n<p>Pfizer’s financial advisers for the transaction are BofA Securities and Centerview Partners LLC, while Guggenheim Securities LLC and Evercore Group LLC advised Arena.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.<img src=\"https://static.tigerbbs.com/baca4cde05c414b1c77aa618108489b1\" tg-width=\"774\" tg-height=\"568\" width=\"100%\" height=\"auto\">Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.</p>\n<p>Pfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.</p>\n<p>Arena is developing several treatments for gastroenterology, dermatology, and cardiology. The drug developer's ulcerative colitis treatment candidate, etrasimod, is in a late-stage study.</p>\n<p>Pfizer said it expects to finance the transaction with cash on hand.</p>\n<p>Pfizer’s financial advisers for the transaction are BofA Securities and Centerview Partners LLC, while Guggenheim Securities LLC and Evercore Group LLC advised Arena.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","ARNA":"阿里那"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167465214","content_text":"Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.\nPfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.\nArena is developing several treatments for gastroenterology, dermatology, and cardiology. The drug developer's ulcerative colitis treatment candidate, etrasimod, is in a late-stage study.\nPfizer said it expects to finance the transaction with cash on hand.\nPfizer’s financial advisers for the transaction are BofA Securities and Centerview Partners LLC, while Guggenheim Securities LLC and Evercore Group LLC advised Arena.","news_type":1},"isVote":1,"tweetType":1,"viewCount":785,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605949536,"gmtCreate":1639105335667,"gmtModify":1639106297586,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605949536","repostId":"1169029812","repostType":4,"repost":{"id":"1169029812","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639073261,"share":"https://www.laohu8.com/m/news/1169029812?lang=&edition=full","pubTime":"2021-12-10 02:07","market":"us","language":"en","title":"Brazilian fintech giant Nubank spikes 26% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1169029812","media":"Tiger Newspress","summary":"Brazilian fintech giant Nubank spikes 26% on its first day of trading.\n\nNu Holdings Ltd.(NU), whose ","content":"<p>Brazilian fintech giant Nubank spikes 26% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/a3329a500714309fd90e7b12ceaef5d0\" tg-width=\"1833\" tg-height=\"825\" width=\"100%\" height=\"auto\"></p>\n<p>Nu Holdings Ltd.(NU), whose backers include Warren Buffett’s Berkshire Hathaway Inc.,also known as Nubank, is headed for its public debut on the NYSE Thursday, as the Brazil-based digital banking platform's initial public offering priced overnight at the top of the expected range. The company raised $2.60 billion, as it sold 289.15 million shares in the IPO, which priced at $9, compared with the expected range of between $8 and $9 a share. With 4.61 billion shares expected after the IPO, the pricing values the company at about $41.48 billion. The stock is expected to begin trading some time after the open under the ticker symbol \"NU.\"</p>\n<p>Berkshire bought 10% of the shares in the offering, said a person familiar with the matter who asked not to be identified because it wasn’t public. Berkshire didn’t immediately respond to a request for comment sent to Buffett’s assistant.</p>\n<p>Nubank’s IPO makes it the most valuable financial institution in Latin America, surpassing Itau Unibanco Holding SA, with a $38 billion market value.</p>\n<p>Sequoia Capital, which invested $1 million in Nubank in 2013 in a seed round, now has a stake that is worth $7.1 billion at the $9 share price, based on the company’s filings. Other top shareholders include DST Global, Tencent and Tiger Global.</p>\n<p><b>Berkshire’s Stake</b></p>\n<p>Berkshire invested in Nubank in June, taking a $500 million stake valuing the company at $30 billion, a person familiar with the matter said at the time.</p>\n<p>Nubank, the world’s biggest standalone digital bank, had more than 48 million customers across Brazil, Mexico and Colombia as of September. It provides easy-to-use financial products that come with relatively low fees.</p>\n<p><b>Expansion Push</b></p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>\n<p>Before creating the startup, Velez spent two years at Sequoia, trying to find an investment in Latin America. Instead he left with an idea of his own.</p>\n<p>Velez, who’s Colombian, had a grueling experience opening a bank account in Brazil and enlisted Junqueira, fresh off a stint at Itau’s credit card unit, to help him create an alternative.</p>\n<p>Brazil, like much of Latin America, is plagued by expensive financial services that are available to only a limited portion of the population. Century-old banks dominate the market beset by bureaucratic barriers. Still, a high percentage of the region’s 700 million people own mobile phones, making it an attractive target for digital banks.</p>\n<p>Velez, whose Class B shares come with 20 votes each compared with one apiece for the Class A shares sold in the IPO, will hold 75% of the company’s voting power after the offering. Junqueira will control 9.3% of the voting power. Neither planned to sell shares in the offering, according to the filings.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brazilian fintech giant Nubank spikes 26% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrazilian fintech giant Nubank spikes 26% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 02:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Brazilian fintech giant Nubank spikes 26% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/a3329a500714309fd90e7b12ceaef5d0\" tg-width=\"1833\" tg-height=\"825\" width=\"100%\" height=\"auto\"></p>\n<p>Nu Holdings Ltd.(NU), whose backers include Warren Buffett’s Berkshire Hathaway Inc.,also known as Nubank, is headed for its public debut on the NYSE Thursday, as the Brazil-based digital banking platform's initial public offering priced overnight at the top of the expected range. The company raised $2.60 billion, as it sold 289.15 million shares in the IPO, which priced at $9, compared with the expected range of between $8 and $9 a share. With 4.61 billion shares expected after the IPO, the pricing values the company at about $41.48 billion. The stock is expected to begin trading some time after the open under the ticker symbol \"NU.\"</p>\n<p>Berkshire bought 10% of the shares in the offering, said a person familiar with the matter who asked not to be identified because it wasn’t public. Berkshire didn’t immediately respond to a request for comment sent to Buffett’s assistant.</p>\n<p>Nubank’s IPO makes it the most valuable financial institution in Latin America, surpassing Itau Unibanco Holding SA, with a $38 billion market value.</p>\n<p>Sequoia Capital, which invested $1 million in Nubank in 2013 in a seed round, now has a stake that is worth $7.1 billion at the $9 share price, based on the company’s filings. Other top shareholders include DST Global, Tencent and Tiger Global.</p>\n<p><b>Berkshire’s Stake</b></p>\n<p>Berkshire invested in Nubank in June, taking a $500 million stake valuing the company at $30 billion, a person familiar with the matter said at the time.</p>\n<p>Nubank, the world’s biggest standalone digital bank, had more than 48 million customers across Brazil, Mexico and Colombia as of September. It provides easy-to-use financial products that come with relatively low fees.</p>\n<p><b>Expansion Push</b></p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>\n<p>Before creating the startup, Velez spent two years at Sequoia, trying to find an investment in Latin America. Instead he left with an idea of his own.</p>\n<p>Velez, who’s Colombian, had a grueling experience opening a bank account in Brazil and enlisted Junqueira, fresh off a stint at Itau’s credit card unit, to help him create an alternative.</p>\n<p>Brazil, like much of Latin America, is plagued by expensive financial services that are available to only a limited portion of the population. Century-old banks dominate the market beset by bureaucratic barriers. Still, a high percentage of the region’s 700 million people own mobile phones, making it an attractive target for digital banks.</p>\n<p>Velez, whose Class B shares come with 20 votes each compared with one apiece for the Class A shares sold in the IPO, will hold 75% of the company’s voting power after the offering. Junqueira will control 9.3% of the voting power. Neither planned to sell shares in the offering, according to the filings.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NU":"Nu Holdings Ltd."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169029812","content_text":"Brazilian fintech giant Nubank spikes 26% on its first day of trading.\n\nNu Holdings Ltd.(NU), whose backers include Warren Buffett’s Berkshire Hathaway Inc.,also known as Nubank, is headed for its public debut on the NYSE Thursday, as the Brazil-based digital banking platform's initial public offering priced overnight at the top of the expected range. The company raised $2.60 billion, as it sold 289.15 million shares in the IPO, which priced at $9, compared with the expected range of between $8 and $9 a share. With 4.61 billion shares expected after the IPO, the pricing values the company at about $41.48 billion. The stock is expected to begin trading some time after the open under the ticker symbol \"NU.\"\nBerkshire bought 10% of the shares in the offering, said a person familiar with the matter who asked not to be identified because it wasn’t public. Berkshire didn’t immediately respond to a request for comment sent to Buffett’s assistant.\nNubank’s IPO makes it the most valuable financial institution in Latin America, surpassing Itau Unibanco Holding SA, with a $38 billion market value.\nSequoia Capital, which invested $1 million in Nubank in 2013 in a seed round, now has a stake that is worth $7.1 billion at the $9 share price, based on the company’s filings. Other top shareholders include DST Global, Tencent and Tiger Global.\nBerkshire’s Stake\nBerkshire invested in Nubank in June, taking a $500 million stake valuing the company at $30 billion, a person familiar with the matter said at the time.\nNubank, the world’s biggest standalone digital bank, had more than 48 million customers across Brazil, Mexico and Colombia as of September. It provides easy-to-use financial products that come with relatively low fees.\nExpansion Push\nThe company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.\nNubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.\nChief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.\nBefore creating the startup, Velez spent two years at Sequoia, trying to find an investment in Latin America. Instead he left with an idea of his own.\nVelez, who’s Colombian, had a grueling experience opening a bank account in Brazil and enlisted Junqueira, fresh off a stint at Itau’s credit card unit, to help him create an alternative.\nBrazil, like much of Latin America, is plagued by expensive financial services that are available to only a limited portion of the population. Century-old banks dominate the market beset by bureaucratic barriers. Still, a high percentage of the region’s 700 million people own mobile phones, making it an attractive target for digital banks.\nVelez, whose Class B shares come with 20 votes each compared with one apiece for the Class A shares sold in the IPO, will hold 75% of the company’s voting power after the offering. Junqueira will control 9.3% of the voting power. Neither planned to sell shares in the offering, according to the filings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602623987,"gmtCreate":1639016602360,"gmtModify":1639016602537,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602623987","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DJX":"1/100道琼斯","DOG":"道指反向ETF","BK4161":"工业机械","QLD":"纳指两倍做多ETF","BK4534":"瑞士信贷持仓","PFE":"辉瑞","TQQQ":"纳指三倍做多ETF","SWK":"美国史丹利公司","SDOW":"道指三倍做空ETF-ProShares","BK4533":"AQR资本管理(全球第二大对冲基金)","PSQ":"纳指反向ETF","BK4007":"制药","BK4566":"资本集团","NCLH":"挪威邮轮","UDOW":"道指三倍做多ETF-ProShares","QQQ":"纳指100ETF","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓",".DJI":"道琼斯","DXD":"道指两倍做空ETF",".IXIC":"NASDAQ Composite","BK4517":"邮轮概念",".SPX":"S&P 500 Index","CCL":"嘉年华邮轮","QID":"纳指两倍做空ETF","DDM":"道指两倍做多ETF","BK4142":"酒店、度假村与豪华游轮","SQQQ":"纳指三倍做空ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606277130,"gmtCreate":1638889423729,"gmtModify":1638889423903,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Okay&nbsp;//<a href=\"https://laohu8.com/U/3574754838536636\">@Ameliakoh</a>:Pls like","listText":"Okay&nbsp;//<a href=\"https://laohu8.com/U/3574754838536636\">@Ameliakoh</a>:Pls like","text":"Okay //@Ameliakoh:Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606277130","repostId":"2189899796","repostType":4,"repost":{"id":"2189899796","pubTimestamp":1638833195,"share":"https://www.laohu8.com/m/news/2189899796?lang=&edition=full","pubTime":"2021-12-07 07:26","market":"us","language":"en","title":"After-Hours Stock Movers: HealthEquity,MongoDB,Silvergate,Shineco and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2189899796","media":"StreetInsider","summary":"After-Hous Stock Movers\nHealthEquity (NASDAQ: HQY) 26% LOWER; reported Q3 EPS of $0.35, in-line with","content":"<p>After-Hous Stock Movers</p>\n<p><a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> (NASDAQ: HQY) 26% LOWER; reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $180 million versus the consensus estimate of $185.05 million. HealthEquity sees FY2022 EPS of $1.30-$1.35, versus the consensus of $1.48. HealthEquity sees FY2022 revenue of $750-755 million, versus the consensus of $762.3 million.</p>\n<p><a href=\"https://laohu8.com/S/ACAD\">ACADIA Pharmaceuticals</a> (Nasdaq: ACAD) 23.8% HIGHER; announced positive top-line results from the pivotal, Phase 3 Lavender study evaluating the efficacy and safety of trofinetide in 187 girls and young women aged 5-20 years with Rett syndrome. The 12-week placebo-controlled study demonstrated a statistically significant improvement over placebo for both co-primary endpoints. On the Rett Syndrome Behaviour Questionnaire (RSBQ), change from baseline to week 12 was -5.1 vs. -1.7 (p=0.0175; effect size=0.37). The Clinical Global ImpressionImprovement (CGI-I) score at week 12 was 3.5 vs. 3.8 (p=0.0030; effect size=0.47). The RSBQ is a caregiver assessment of the core symptoms of Rett syndrome and the CGI-I is a global physician assessment of worsening or improving of Rett syndrome.</p>\n<p><a href=\"https://laohu8.com/S/MDB\">MongoDB Inc.</a> (NASDAQ: MDB) 15.5% HIGHER; reported Q3 EPS of ($0.11), $0.26 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $226.9 million versus the consensus estimate of $205.14 million. MongoDB sees Q4 2022 EPS of ($0.24)-($0.21), versus the consensus of ($0.34). MongoDB sees Q4 2022 revenue of $239-242 million, versus the consensus of $227.7 million.</p>\n<p><a href=\"https://laohu8.com/S/OWL\">Blue Owl Capital Inc.</a> (NYSE: OWL) 10.8% LOWER; announced today that NBSH Blue Investments II, LLC, intends to offer in an underwritten public offering 26,717,377 shares of the Company's Class A common stock.</p>\n<p><a href=\"https://laohu8.com/S/TSHA\">Taysha Gene Therapies, Inc.</a> (Nasdaq: TSHA) 10.7% HIGHER; announced a late-breaking abstract and poster presentation by Dr. Rachel Bailey, Assistant Professor at UT Southwestern Medical Center on positive preclinical data for TSHA-105, an AAV9-based gene therapy in development for SLC13A5-related epilepsy at the American Epilepsy Society Annual Meeting on December 6th 2021.</p>\n<p><a href=\"https://laohu8.com/S/SI\">Silvergate Capital</a> Corporation (NYSE: SI) 7% LOWER; announced today the launch of an underwritten public offering of $400 million of shares of Class A common stock. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $60 million of shares of Class A common stock.</p>\n<p><a href=\"https://laohu8.com/S/SISI\">Shineco, Inc.</a> (NASDAQ: SISI) 7% LOWER; entered into a securities purchase agreement (the “Agreement”) for the sale of Gross Proceeds US$2.0 million of its registered common stock at a price of $6.8546 per share with GHS Investments, LLC.</p>\n<p><a href=\"https://laohu8.com/S/DWAC\">Digital World Acquisition Corp</a> (NASDAQ: DWAC) 5.6% HIGHER; Trump Media &amp; Technology Group (TMTG) today announced that Congressman Devin G. Nunes has been selected to join the Company as Chief Executive Officer. Mr. Nunes is currently a sitting U.S. House Representative, representing Californias 22nd congressional district, and formerly the Chair of the House Intelligence Committee. Mr. Nunes will be leaving the U.S. House of Representatives and will begin his new role as Chief Executive Officer of TMTG in January 2022.</p>\n<p><a href=\"https://laohu8.com/S/GLPI\">Gaming and Leisure Properties</a> (NASDAQ: GLPI) 3.2% LOWER; today announced that it has commenced an underwritten public offering to sell 7,700,000 shares of common stock</p>\n<p><a href=\"https://laohu8.com/S/SUMO\">Sumo Logic, Inc.</a> (NASDAQ: SUMO) 2% HIGHER; reported Q3 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $62 million versus the consensus estimate of $60.86 million. Sumo Logic Inc. sees FY2022 EPS of ($0.51)-($0.50), versus the consensus of ($0.51). Sumo Logic Inc. sees FY2022 revenue of $238-239.8 million, versus the consensus of $238 million.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: HealthEquity,MongoDB,Silvergate,Shineco and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: HealthEquity,MongoDB,Silvergate,Shineco and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 07:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19315575><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hous Stock Movers\nHealthEquity (NASDAQ: HQY) 26% LOWER; reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $180 million versus the consensus...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19315575\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HQY":"HealthEquity","MDB":"MongoDB Inc.","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","BK4154":"管理型保健护理","BK4211":"区域性银行","ACAD":"阿卡迪亚","BK4116":"互联网服务与基础架构","OWL":"Blue Owl Capital Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19315575","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189899796","content_text":"After-Hous Stock Movers\nHealthEquity (NASDAQ: HQY) 26% LOWER; reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $180 million versus the consensus estimate of $185.05 million. HealthEquity sees FY2022 EPS of $1.30-$1.35, versus the consensus of $1.48. HealthEquity sees FY2022 revenue of $750-755 million, versus the consensus of $762.3 million.\nACADIA Pharmaceuticals (Nasdaq: ACAD) 23.8% HIGHER; announced positive top-line results from the pivotal, Phase 3 Lavender study evaluating the efficacy and safety of trofinetide in 187 girls and young women aged 5-20 years with Rett syndrome. The 12-week placebo-controlled study demonstrated a statistically significant improvement over placebo for both co-primary endpoints. On the Rett Syndrome Behaviour Questionnaire (RSBQ), change from baseline to week 12 was -5.1 vs. -1.7 (p=0.0175; effect size=0.37). The Clinical Global ImpressionImprovement (CGI-I) score at week 12 was 3.5 vs. 3.8 (p=0.0030; effect size=0.47). The RSBQ is a caregiver assessment of the core symptoms of Rett syndrome and the CGI-I is a global physician assessment of worsening or improving of Rett syndrome.\nMongoDB Inc. (NASDAQ: MDB) 15.5% HIGHER; reported Q3 EPS of ($0.11), $0.26 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $226.9 million versus the consensus estimate of $205.14 million. MongoDB sees Q4 2022 EPS of ($0.24)-($0.21), versus the consensus of ($0.34). MongoDB sees Q4 2022 revenue of $239-242 million, versus the consensus of $227.7 million.\nBlue Owl Capital Inc. (NYSE: OWL) 10.8% LOWER; announced today that NBSH Blue Investments II, LLC, intends to offer in an underwritten public offering 26,717,377 shares of the Company's Class A common stock.\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA) 10.7% HIGHER; announced a late-breaking abstract and poster presentation by Dr. Rachel Bailey, Assistant Professor at UT Southwestern Medical Center on positive preclinical data for TSHA-105, an AAV9-based gene therapy in development for SLC13A5-related epilepsy at the American Epilepsy Society Annual Meeting on December 6th 2021.\nSilvergate Capital Corporation (NYSE: SI) 7% LOWER; announced today the launch of an underwritten public offering of $400 million of shares of Class A common stock. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $60 million of shares of Class A common stock.\nShineco, Inc. (NASDAQ: SISI) 7% LOWER; entered into a securities purchase agreement (the “Agreement”) for the sale of Gross Proceeds US$2.0 million of its registered common stock at a price of $6.8546 per share with GHS Investments, LLC.\nDigital World Acquisition Corp (NASDAQ: DWAC) 5.6% HIGHER; Trump Media & Technology Group (TMTG) today announced that Congressman Devin G. Nunes has been selected to join the Company as Chief Executive Officer. Mr. Nunes is currently a sitting U.S. House Representative, representing Californias 22nd congressional district, and formerly the Chair of the House Intelligence Committee. Mr. Nunes will be leaving the U.S. House of Representatives and will begin his new role as Chief Executive Officer of TMTG in January 2022.\nGaming and Leisure Properties (NASDAQ: GLPI) 3.2% LOWER; today announced that it has commenced an underwritten public offering to sell 7,700,000 shares of common stock\nSumo Logic, Inc. (NASDAQ: SUMO) 2% HIGHER; reported Q3 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $62 million versus the consensus estimate of $60.86 million. Sumo Logic Inc. sees FY2022 EPS of ($0.51)-($0.50), versus the consensus of ($0.51). Sumo Logic Inc. sees FY2022 revenue of $238-239.8 million, versus the consensus of $238 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606272507,"gmtCreate":1638889269555,"gmtModify":1638889269705,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606272507","repostId":"1125480084","repostType":4,"repost":{"id":"1125480084","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638881131,"share":"https://www.laohu8.com/m/news/1125480084?lang=&edition=full","pubTime":"2021-12-07 20:45","market":"us","language":"en","title":"10 Biggest Price Target Changes For Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1125480084","media":"Benzinga","summary":"Oppenheimer cut the price target on Coupa Software Incorporated from $275 to $225. Coupa Software sh","content":"<ul>\n <li>Oppenheimer cut the price target on&nbsp;<b>Coupa Software Incorporated</b>&nbsp;from $275 to $225. Coupa Software shares fell 12.6% to $152.10 in pre-market trading.</li>\n <li>JMP Securities raised&nbsp;<b>ACADIA Pharmaceuticals Inc.</b>&nbsp;price target from $35 to $39. ACADIA Pharmaceuticals shares rose 16.3% to $22.57 in pre-market trading.</li>\n <li>RBC Capital lowered&nbsp;<b>HealthEquity, Inc.</b>&nbsp;price target from $87 to $70. HealthEquity shares fell 22.4% to $43.96 pre-market trading.</li>\n <li>Needham raised the price target on&nbsp;<b>MongoDB, Inc.</b>&nbsp;from $534 to $626. MongoDB shares rose 21.1% to $520.00 in pre-market trading.</li>\n <li>Cowen &amp; Co. cut&nbsp;<b>Ross Stores, Inc.</b>&nbsp;price target from $131 to $109. Ross Stores shares fell 1% to $111.59 in pre-market trading.</li>\n <li>MKM Partners boosted the price target for&nbsp;<b>Starbucks Corporation</b>&nbsp;from $114 to $130. Starbucks shares rose 2.1% to $115.68 in pre-market trading.</li>\n <li>JP Morgan raised&nbsp;<b>Murphy Oil Corporation</b>&nbsp;price target from $29 to $37. Murphy Oil shares fell 0.6% to $27.25 in pre-market trading.</li>\n <li>Jefferies boosted the price target on&nbsp;<b>Juniper Networks, Inc.</b>&nbsp;from $28 to $42. Juniper Networks shares climbed 3% to $32.40 in pre-market trading.</li>\n <li>Deutsche Bank cut the price target for&nbsp;<b>Jack in the Box Inc.</b>&nbsp;from $122 to $108. Jack in the Box shares rose 5.3% to $84.83 in pre-market trading.</li>\n <li>Keybanc lowered&nbsp;<b>GitLab Inc.</b>&nbsp;price target from $144 to $115. GitLab shares fell 3.4% to $86.00 in pre-market trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-07 20:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Oppenheimer cut the price target on&nbsp;<b>Coupa Software Incorporated</b>&nbsp;from $275 to $225. Coupa Software shares fell 12.6% to $152.10 in pre-market trading.</li>\n <li>JMP Securities raised&nbsp;<b>ACADIA Pharmaceuticals Inc.</b>&nbsp;price target from $35 to $39. ACADIA Pharmaceuticals shares rose 16.3% to $22.57 in pre-market trading.</li>\n <li>RBC Capital lowered&nbsp;<b>HealthEquity, Inc.</b>&nbsp;price target from $87 to $70. HealthEquity shares fell 22.4% to $43.96 pre-market trading.</li>\n <li>Needham raised the price target on&nbsp;<b>MongoDB, Inc.</b>&nbsp;from $534 to $626. MongoDB shares rose 21.1% to $520.00 in pre-market trading.</li>\n <li>Cowen &amp; Co. cut&nbsp;<b>Ross Stores, Inc.</b>&nbsp;price target from $131 to $109. Ross Stores shares fell 1% to $111.59 in pre-market trading.</li>\n <li>MKM Partners boosted the price target for&nbsp;<b>Starbucks Corporation</b>&nbsp;from $114 to $130. Starbucks shares rose 2.1% to $115.68 in pre-market trading.</li>\n <li>JP Morgan raised&nbsp;<b>Murphy Oil Corporation</b>&nbsp;price target from $29 to $37. Murphy Oil shares fell 0.6% to $27.25 in pre-market trading.</li>\n <li>Jefferies boosted the price target on&nbsp;<b>Juniper Networks, Inc.</b>&nbsp;from $28 to $42. Juniper Networks shares climbed 3% to $32.40 in pre-market trading.</li>\n <li>Deutsche Bank cut the price target for&nbsp;<b>Jack in the Box Inc.</b>&nbsp;from $122 to $108. Jack in the Box shares rose 5.3% to $84.83 in pre-market trading.</li>\n <li>Keybanc lowered&nbsp;<b>GitLab Inc.</b>&nbsp;price target from $144 to $115. GitLab shares fell 3.4% to $86.00 in pre-market trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","MUR":"墨菲石油","COUP":"Coupa Software Inc","JNPR":"瞻博网络","JACK":"Jack In The Box Inc","MDB":"MongoDB Inc.","HQY":"HealthEquity","ACAD":"阿卡迪亚","ROST":"罗斯百货有限公司","GTLB":"GitLab, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125480084","content_text":"Oppenheimer cut the price target on Coupa Software Incorporated from $275 to $225. Coupa Software shares fell 12.6% to $152.10 in pre-market trading.\nJMP Securities raised ACADIA Pharmaceuticals Inc. price target from $35 to $39. ACADIA Pharmaceuticals shares rose 16.3% to $22.57 in pre-market trading.\nRBC Capital lowered HealthEquity, Inc. price target from $87 to $70. HealthEquity shares fell 22.4% to $43.96 pre-market trading.\nNeedham raised the price target on MongoDB, Inc. from $534 to $626. MongoDB shares rose 21.1% to $520.00 in pre-market trading.\nCowen & Co. cut Ross Stores, Inc. price target from $131 to $109. Ross Stores shares fell 1% to $111.59 in pre-market trading.\nMKM Partners boosted the price target for Starbucks Corporation from $114 to $130. Starbucks shares rose 2.1% to $115.68 in pre-market trading.\nJP Morgan raised Murphy Oil Corporation price target from $29 to $37. Murphy Oil shares fell 0.6% to $27.25 in pre-market trading.\nJefferies boosted the price target on Juniper Networks, Inc. from $28 to $42. Juniper Networks shares climbed 3% to $32.40 in pre-market trading.\nDeutsche Bank cut the price target for Jack in the Box Inc. from $122 to $108. Jack in the Box shares rose 5.3% to $84.83 in pre-market trading.\nKeybanc lowered GitLab Inc. price target from $144 to $115. GitLab shares fell 3.4% to $86.00 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608554874,"gmtCreate":1638764447008,"gmtModify":1638764447128,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"💪💪","listText":"💪💪","text":"💪💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608554874","repostId":"1127164143","repostType":4,"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601115913,"gmtCreate":1638497431203,"gmtModify":1638497431315,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601115913","repostId":"2188548587","repostType":4,"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601135719,"gmtCreate":1638496910532,"gmtModify":1638496939041,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"//<a href=\"https://laohu8.com/U/4091932914422900\">@Abbas99m</a>:Wow","listText":"//<a href=\"https://laohu8.com/U/4091932914422900\">@Abbas99m</a>:Wow","text":"//@Abbas99m:Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601135719","repostId":"1114050476","repostType":4,"repost":{"id":"1114050476","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638458568,"share":"https://www.laohu8.com/m/news/1114050476?lang=&edition=full","pubTime":"2021-12-02 23:22","market":"us","language":"en","title":"Crypto stocks slid in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1114050476","media":"Tiger Newspress","summary":"Crypto stocks slid in morning trading.Bit Digital,Riot Blockchain,Square,Marathon Digital,CanaanBIT ","content":"<p>Crypto stocks slid in morning trading.Bit Digital,Riot Blockchain,Square,Marathon Digital,CanaanBIT Mining,&nbsp;SoS Ltd&nbsp;and&nbsp;Coinbase&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/8474a9e6b11c14ae3e40c786fb41c312\" tg-width=\"400\" tg-height=\"602\" width=\"100%\" height=\"auto\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto stocks slid in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto stocks slid in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-02 23:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto stocks slid in morning trading.Bit Digital,Riot Blockchain,Square,Marathon Digital,CanaanBIT Mining,&nbsp;SoS Ltd&nbsp;and&nbsp;Coinbase&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/8474a9e6b11c14ae3e40c786fb41c312\" tg-width=\"400\" tg-height=\"602\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BTBT":"Bit Digital, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114050476","content_text":"Crypto stocks slid in morning trading.Bit Digital,Riot Blockchain,Square,Marathon Digital,CanaanBIT Mining, SoS Ltd and Coinbase fell between 1% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603673610,"gmtCreate":1638408929389,"gmtModify":1638408929611,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👌 okay&nbsp;","listText":"👌 okay&nbsp;","text":"👌 okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603673610","repostId":"2188568514","repostType":4,"repost":{"id":"2188568514","pubTimestamp":1638365160,"share":"https://www.laohu8.com/m/news/2188568514?lang=&edition=full","pubTime":"2021-12-01 21:26","market":"us","language":"en","title":"5 Top Stocks To Buy in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2188568514","media":"Motley Fool","summary":"The weather is turning colder, but these stocks could heat up your portfolio.","content":"<p>Earnings season is in the rearview mirror, and the holiday season is afoot. Warnings of a new Covid variant are rocking markets again, as are threats of a tightening monetary policy. The stock market may be uncertain, but there are still plenty of opportunities for savvy investors.</p>\n<p>If you're looking for new ideas, keep reading to see why our writers recommend <b>Teladoc&nbsp;</b>(NYSE:TDOC), <b>Duolingo&nbsp;</b>(NASDAQ:DUOL),&nbsp;<b>AT&amp;T&nbsp;</b>(NYSE:T),&nbsp;<b><a href=\"https://laohu8.com/S/MELI\">MercadoLibre</a> </b>(NASDAQ:MELI) and&nbsp;<b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications </b>(Nasdaq: ZM)&nbsp;as top stocks to buy in December.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c5020cd3e804f600834231b1bf84608f\" tg-width=\"700\" tg-height=\"356\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Omicron short term, disruptor long term</h2>\n<p><b>Keith Speights (Teladoc Health)</b>: There's a good chance that the omicron variant will be the most important factor affecting the stock market in December. If that's the case, Teladoc Health is likely to be one of the biggest winners over the short term.</p>\n<p>Teladoc's shares skyrocketed last year as the COVID-19 pandemic fueled a massive acceleration in the use of telehealth. I don't think that the widespread lockdowns of 2020 will return. However, as long as there is uncertainty about the omicron variant, Teladoc is likely to benefit.</p>\n<p>But I don't view Teladoc as merely a short-term play. Over the long term, I think that the company will be an exciting disruptor of healthcare. Actually, it already is.</p>\n<p>More than half of the Fortune 500 have signed up with Teladoc. They've turned to the company's virtual care services because of lower costs and greater convenience for patients. Those advantages won't disappear once the pandemic is over.</p>\n<p>Teladoc's acquisition of Livongo Health puts the company in the driver's seat in digital chronic disease management. Its new Primary 360 product should make Teladoc an even more formidable competitor in virtual care. Primary360 allows individuals to select a primary care provider that they see virtually, and with whom they can develop an ongoing relationship.</p>\n<p>The adoption of virtual care is still only in its early stages. I think that Teladoc could easily deliver a 5X return or more over the next decade.</p>\n<h2>Yo quiero comprar esta acción</h2>\n<p><b>Anders Bylund (Duolingo):</b> Language-learning service operator <b>Duolingo</b> (NASDAQ:DUOL) has hardly missed a step in the last three months. The company added a couple of high-powered names to its executive suite and delivered year-end guidance far above Wall Street's expectations. Sure enough, the stock rose from $120 per share in late August to $202 in the second half of September.</p>\n<p>...and then Duolingo fell into Wall Street's bargain bin. The stock is now back where it was three months ago, and I think the buying window is wide open.</p>\n<p>The business is firing on every available cylinder. Subscription revenues rose by 42% year over year in the third quarter. Advertising sales also jumped 34% higher. The company's \"other\" revenues, mainly related to in-app purchases, scored a 179% sales boost. And the future looks even brighter. Bookings increased by 57%, indicating a growing trend in subscription-based sales.</p>\n<p>That's not all. Duolingo has much bigger plans for its education and tutoring services, far beyond its current niche in teaching foreign languages. The company's mission is to \"develop the best education in the world and make it universally available.\" You should expect the company to start making those moves soon.</p>\n<p>\"We made strong progress on our mission this past quarter, and we have exciting plans for the future,\" said co-founder and CEO Luis von Ahn in the third-quarter earnings call. \"I plan to devote my life to this mission.\"</p>\n<p>Furthermore, Duolingo now has an official head of animation and scripted content. Linda Simensky, former content development chief at PBS Kids, is already sketching out animated shows featuring Duolingo's cast of characters. I expect a serious marketing push to go along with her content development efforts.</p>\n<p>And you can buy into this ambitious plan of world domination at a 42% discount from September's highs. I think we'll eventually look back at Duolingo's $4.6 billion market cap in the fall of 2021 and call it quaintly small. This stock has a lot of growing left to do, and it trades at a reasonable price right now.</p>\n<h2>Extreme pessimism</h2>\n<p><b>Tim Green (AT&amp;T)</b>: Telecom giant AT&amp;T has spent the past six years making costly mistakes. In an ill-fated attempt to transform itself into an entertainment conglomerate, AT&amp;T racked up debt by pouring tens of billions of dollars into questionable acquisitions.</p>\n<p>AT&amp;T spent $67 billion, including assumed debt, on DirecTV in 2015. After years of shedding subscribers, the company offloaded DirecTV at a fraction of what it paid in a private equity deal earlier this year. The $109 billion acquisition of Time Warner, which closed in 2018 after a long battle with regulators, is set to come to a similar end. Time Warner, now called WarnerMedia, will be merged with <b>Discovery</b> (NASDAQ:DISCA) by mid-2022.</p>\n<p>AT&amp;T and its shareholders would have been better off if the company hadn't embarked on its failed foray into the media business. But if you're investing in AT&amp;T today, you're not buying those past mistakes. You're buying a cash-cow telecom business that will soon be free from distractions, along with a piece of a new content company that should be a major player in the streaming market.</p>\n<p>AT&amp;T expects to generate around $20 billion of free cash flow annually once the deal closes. The company is currently valued around $170 billion, a pessimistic valuation to say the least. The new content company expects to produce around $8 billion in annual free cash flow starting in 2023.</p>\n<p>These estimates could certainly be overly optimistic. The latter assumes $3 billion in cost synergies, which should always be taken with a grain of salt. But even if they are off base, AT&amp;T's stock has been beaten down so much that the downside looks limited. With AT&amp;T, you get a telecom giant gushing cash and, next year, a portion of a streaming giant with a vast catalog of content. It looks like a pretty good bet to me.</p>\n<h2>Another way to play the holiday season</h2>\n<p><b>Jeremy Bowman (MercadoLibre):&nbsp;</b>December marks the busiest time of year for retailers and other consumer-facing businesses, and that phenomenon extends beyond the U.S. into Latin America and elsewhere.</p>\n<p>That's one reason to consider MercadoLibre, a Latin American e-commerce and digital payments giant, which is benefiting from a number of tailwinds, including the boom in its core businesses sparked by the coronavirus pandemic. The fourth quarter is typically the company's strongest of the year, yet the stock is trading at a 52-week-lows for no good reason other than the broader sell-off in growth stocks amid fears of tightening monetary policy and rising interest rates, which make growth stocks less attractive.</p>\n<p>However, MercadoLibre's third quarter shows why the stock is so attractive, especially at its current valuation. Gross merchandise volume (GMV) increased 30% year over year on a currency-neutral basis to $7.3 billion, while currency-neutral revenue jumped 73% to $1.9 billion. At the same time, earnings per share jumped from $0.28 to $1.92 year over year, showing that the business is rapidly gaining scale.</p>\n<p>MercadoLibre looks particularly appealing at the current price because the company is becoming much more than an e-commerce business. In addition to Mercado Pago, its digital payments product, it also had fast-growing businesses in logistics with Mercado Envios, financing with Mercado Credito, and an asset management arm, Mercado Fondo. Altogether, it shows a company building an impressive network of businesses that reinforce each other and build the company's competitive advantages.</p>\n<p>MercadoLibre has been a longtime winner on the stock market, and taking advantage of this dip should reward investors once again.</p>\n<h2>A fallen angel</h2>\n<p><b>Brian Feroldi (Zoom Video Communications)</b>: Companies that benefited from stay-at-home orders <i>soared</i> in 2020. No company illustrates that point better than <b>Zoom Video Communications </b>(NASDAQ:ZM). Shares of the leading video communication platform skyrocketed more than 395% during the year. However, investors have been fleeing from stocks that benefited from COVID throughout 2021. That mass sell-off has crushed Zoom's stock and put its shares in the bargain bin. I think that's providing investors with an opportune time to get in.</p>\n<p>Zoom's recent quarterly results show that its high-growth days are far from over. Zoom's revenue grew 35% year over year in the third quarter to $1.05 billion. Better yet, its margins expanded across the board. That allowed its adjusted earnings per share to jump 68% to $1.11. Clearly, the reopening of the world hasn't been bad for businesses.</p>\n<p>If that wasn't impressive enough, Zoom also raised its full-year guidance. Management now expects revenue to land between $4.079 billion to $4.081 billion (up from $4.005 billion to $4.015 billion). This represents more than 50% growth from 2020. What's more, Wall Street expects Zoom's revenue to grow another 16% in 2022. These numbers tell me that the bull case for owning Zoom's stock is hardly firmly intact.</p>\n<p>There's no doubt in my mind that Zoom's growth will continue to slow in the coming years, but I also firmly believe that flex work is here to stay. That means that the long-term demand for high-quality video software will remain strong for years. As a leader in the field, Zoom looks poised to benefit from that mega-trend.</p>\n<p>Meanwhile, Zoom's stock has fallen so much that its valuation is finally looking reasonable. Shares are trading for less than 45 times next year's adjusted earnings estimates, and under 18 times sales. While these numbers might not look classically \"cheap\", I think they are a bargain price to pay for a high-quality business.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks To Buy in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks To Buy in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 21:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/01/5-top-stocks-to-buy-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Earnings season is in the rearview mirror, and the holiday season is afoot. Warnings of a new Covid variant are rocking markets again, as are threats of a tightening monetary policy. The stock market ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/01/5-top-stocks-to-buy-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","T":"美国电话电报","BK4504":"桥水持仓","DUOL":"多邻国","MELI":"MercadoLibre","ZM":"Zoom","BK4125":"广播","BK4548":"巴美列捷福持仓","QNETCN":"纳斯达克中美互联网老虎指数","DISCA":"探索传播","BK4539":"次新股","BK4528":"SaaS概念","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4204":"教育服务","BK4507":"流媒体概念","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4566":"资本集团","BK4525":"远程办公概念","TDOC":"Teladoc Health Inc.","BK4535":"淡马锡持仓","BK4167":"医疗保健技术","BK4550":"红杉资本持仓","BK4115":"综合电信业务","BK4552":"Archegos爆仓风波概念","BK4122":"互联网与直销零售"},"source_url":"https://www.fool.com/investing/2021/12/01/5-top-stocks-to-buy-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188568514","content_text":"Earnings season is in the rearview mirror, and the holiday season is afoot. Warnings of a new Covid variant are rocking markets again, as are threats of a tightening monetary policy. The stock market may be uncertain, but there are still plenty of opportunities for savvy investors.\nIf you're looking for new ideas, keep reading to see why our writers recommend Teladoc (NYSE:TDOC), Duolingo (NASDAQ:DUOL), AT&T (NYSE:T), MercadoLibre (NASDAQ:MELI) and Zoom Video Communications (Nasdaq: ZM) as top stocks to buy in December.\nImage source: Getty Images.\nOmicron short term, disruptor long term\nKeith Speights (Teladoc Health): There's a good chance that the omicron variant will be the most important factor affecting the stock market in December. If that's the case, Teladoc Health is likely to be one of the biggest winners over the short term.\nTeladoc's shares skyrocketed last year as the COVID-19 pandemic fueled a massive acceleration in the use of telehealth. I don't think that the widespread lockdowns of 2020 will return. However, as long as there is uncertainty about the omicron variant, Teladoc is likely to benefit.\nBut I don't view Teladoc as merely a short-term play. Over the long term, I think that the company will be an exciting disruptor of healthcare. Actually, it already is.\nMore than half of the Fortune 500 have signed up with Teladoc. They've turned to the company's virtual care services because of lower costs and greater convenience for patients. Those advantages won't disappear once the pandemic is over.\nTeladoc's acquisition of Livongo Health puts the company in the driver's seat in digital chronic disease management. Its new Primary 360 product should make Teladoc an even more formidable competitor in virtual care. Primary360 allows individuals to select a primary care provider that they see virtually, and with whom they can develop an ongoing relationship.\nThe adoption of virtual care is still only in its early stages. I think that Teladoc could easily deliver a 5X return or more over the next decade.\nYo quiero comprar esta acción\nAnders Bylund (Duolingo): Language-learning service operator Duolingo (NASDAQ:DUOL) has hardly missed a step in the last three months. The company added a couple of high-powered names to its executive suite and delivered year-end guidance far above Wall Street's expectations. Sure enough, the stock rose from $120 per share in late August to $202 in the second half of September.\n...and then Duolingo fell into Wall Street's bargain bin. The stock is now back where it was three months ago, and I think the buying window is wide open.\nThe business is firing on every available cylinder. Subscription revenues rose by 42% year over year in the third quarter. Advertising sales also jumped 34% higher. The company's \"other\" revenues, mainly related to in-app purchases, scored a 179% sales boost. And the future looks even brighter. Bookings increased by 57%, indicating a growing trend in subscription-based sales.\nThat's not all. Duolingo has much bigger plans for its education and tutoring services, far beyond its current niche in teaching foreign languages. The company's mission is to \"develop the best education in the world and make it universally available.\" You should expect the company to start making those moves soon.\n\"We made strong progress on our mission this past quarter, and we have exciting plans for the future,\" said co-founder and CEO Luis von Ahn in the third-quarter earnings call. \"I plan to devote my life to this mission.\"\nFurthermore, Duolingo now has an official head of animation and scripted content. Linda Simensky, former content development chief at PBS Kids, is already sketching out animated shows featuring Duolingo's cast of characters. I expect a serious marketing push to go along with her content development efforts.\nAnd you can buy into this ambitious plan of world domination at a 42% discount from September's highs. I think we'll eventually look back at Duolingo's $4.6 billion market cap in the fall of 2021 and call it quaintly small. This stock has a lot of growing left to do, and it trades at a reasonable price right now.\nExtreme pessimism\nTim Green (AT&T): Telecom giant AT&T has spent the past six years making costly mistakes. In an ill-fated attempt to transform itself into an entertainment conglomerate, AT&T racked up debt by pouring tens of billions of dollars into questionable acquisitions.\nAT&T spent $67 billion, including assumed debt, on DirecTV in 2015. After years of shedding subscribers, the company offloaded DirecTV at a fraction of what it paid in a private equity deal earlier this year. The $109 billion acquisition of Time Warner, which closed in 2018 after a long battle with regulators, is set to come to a similar end. Time Warner, now called WarnerMedia, will be merged with Discovery (NASDAQ:DISCA) by mid-2022.\nAT&T and its shareholders would have been better off if the company hadn't embarked on its failed foray into the media business. But if you're investing in AT&T today, you're not buying those past mistakes. You're buying a cash-cow telecom business that will soon be free from distractions, along with a piece of a new content company that should be a major player in the streaming market.\nAT&T expects to generate around $20 billion of free cash flow annually once the deal closes. The company is currently valued around $170 billion, a pessimistic valuation to say the least. The new content company expects to produce around $8 billion in annual free cash flow starting in 2023.\nThese estimates could certainly be overly optimistic. The latter assumes $3 billion in cost synergies, which should always be taken with a grain of salt. But even if they are off base, AT&T's stock has been beaten down so much that the downside looks limited. With AT&T, you get a telecom giant gushing cash and, next year, a portion of a streaming giant with a vast catalog of content. It looks like a pretty good bet to me.\nAnother way to play the holiday season\nJeremy Bowman (MercadoLibre): December marks the busiest time of year for retailers and other consumer-facing businesses, and that phenomenon extends beyond the U.S. into Latin America and elsewhere.\nThat's one reason to consider MercadoLibre, a Latin American e-commerce and digital payments giant, which is benefiting from a number of tailwinds, including the boom in its core businesses sparked by the coronavirus pandemic. The fourth quarter is typically the company's strongest of the year, yet the stock is trading at a 52-week-lows for no good reason other than the broader sell-off in growth stocks amid fears of tightening monetary policy and rising interest rates, which make growth stocks less attractive.\nHowever, MercadoLibre's third quarter shows why the stock is so attractive, especially at its current valuation. Gross merchandise volume (GMV) increased 30% year over year on a currency-neutral basis to $7.3 billion, while currency-neutral revenue jumped 73% to $1.9 billion. At the same time, earnings per share jumped from $0.28 to $1.92 year over year, showing that the business is rapidly gaining scale.\nMercadoLibre looks particularly appealing at the current price because the company is becoming much more than an e-commerce business. In addition to Mercado Pago, its digital payments product, it also had fast-growing businesses in logistics with Mercado Envios, financing with Mercado Credito, and an asset management arm, Mercado Fondo. Altogether, it shows a company building an impressive network of businesses that reinforce each other and build the company's competitive advantages.\nMercadoLibre has been a longtime winner on the stock market, and taking advantage of this dip should reward investors once again.\nA fallen angel\nBrian Feroldi (Zoom Video Communications): Companies that benefited from stay-at-home orders soared in 2020. No company illustrates that point better than Zoom Video Communications (NASDAQ:ZM). Shares of the leading video communication platform skyrocketed more than 395% during the year. However, investors have been fleeing from stocks that benefited from COVID throughout 2021. That mass sell-off has crushed Zoom's stock and put its shares in the bargain bin. I think that's providing investors with an opportune time to get in.\nZoom's recent quarterly results show that its high-growth days are far from over. Zoom's revenue grew 35% year over year in the third quarter to $1.05 billion. Better yet, its margins expanded across the board. That allowed its adjusted earnings per share to jump 68% to $1.11. Clearly, the reopening of the world hasn't been bad for businesses.\nIf that wasn't impressive enough, Zoom also raised its full-year guidance. Management now expects revenue to land between $4.079 billion to $4.081 billion (up from $4.005 billion to $4.015 billion). This represents more than 50% growth from 2020. What's more, Wall Street expects Zoom's revenue to grow another 16% in 2022. These numbers tell me that the bull case for owning Zoom's stock is hardly firmly intact.\nThere's no doubt in my mind that Zoom's growth will continue to slow in the coming years, but I also firmly believe that flex work is here to stay. That means that the long-term demand for high-quality video software will remain strong for years. As a leader in the field, Zoom looks poised to benefit from that mega-trend.\nMeanwhile, Zoom's stock has fallen so much that its valuation is finally looking reasonable. Shares are trading for less than 45 times next year's adjusted earnings estimates, and under 18 times sales. While these numbers might not look classically \"cheap\", I think they are a bargain price to pay for a high-quality business.","news_type":1},"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603670645,"gmtCreate":1638408797572,"gmtModify":1638408797816,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603670645","repostId":"1116584621","repostType":4,"repost":{"id":"1116584621","pubTimestamp":1638366346,"share":"https://www.laohu8.com/m/news/1116584621?lang=&edition=full","pubTime":"2021-12-01 21:45","market":"us","language":"en","title":"What Shareholders Can Expect From Musk’s New Tesla Roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=1116584621","media":"Bloomberg","summary":"Elon Musk tweeted early this week that he will be on Tesla’s next earnings call in January and provi","content":"<p>Elon Musk&nbsp;tweeted&nbsp;early this week that he will be on Tesla’s next earnings call in January and provide an “updated product roadmap.” He’ll also talk about this year’s “supply chain nightmare.”</p>\n<p>Musk sees everything that the company does — including building new factories in Austin, Texas, and near Berlin — as Tesla products. So while he will likely focus on vehicles on the horizon, I expect we’ll get an update on the progress of the factories, too. We could also hear&nbsp;about any number of other products, including&nbsp;Tesla Insurance; fans might even be able to get a&nbsp;$50 whistle&nbsp;shaped like the Cybertruck, assuming it’s ever back in stock.</p>\n<p>To review: Tesla currently makes the Model S, X, 3 and Y in Fremont, California, and the Model 3 and Y in Shanghai. Tesla also is building a new factory in Lathrop, California, for Megapack,&nbsp;its utility-scale battery product.</p>\n<p>Here’s a quick reminder of everything else that Tesla has unveiled and that customers and investors are eager for updates on.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/35dc043d86f20335c3ce1e3d7ee1e5f9\" tg-width=\"1024\" tg-height=\"599\" width=\"100%\" height=\"auto\"><span>Elon Musk presents the Tesla Cybertruck.</span></p>\n<p><b>CYBERTRUCK</b></p>\n<p>Musk unveiled the Cybertruck two years ago, in November 2019. Of all the vehicles on Tesla’s plate, the Cybertruck is the one that has generated the most interest. The idea is to make it in Austin, Texas, after the Model Y. Tesla’s website, which still takes fully refundable $100 deposits for the Cybertruck, says “you will be able to complete your configuration as production nears in 2022.” I would not be surprised if this timeline slips further.</p>\n<p><b>SEMI</b></p>\n<p>Musk unveiled the Semi truck four years ago, in November 2017. Musk has suggested the Semi is on hold until Tesla can make or source a new type of battery cell in high volume. The new, larger 4680 battery cells were one of the big highlights of Tesla’s “Battery Day” last year. Tesla is making the 4680s on a pilot line in Fremont, but also plans to procure them from long-time supplier Panasonic. In its third quarter earnings release, Tesla said that “the 4680 in-house cell project continues to progress. We are producing an increasing number of battery packs for testing purposes, and so far, the test results meet our current expectations.” That sounds promising, but volume production remains a work in progress.</p>\n<p><b>ROADSTER</b></p>\n<p>The big reveal at the Semi event in November 2017 was chief designer Franz von Holzhausen driving the next-generation Roadster out of the back of the Semi. We haven’t heard about this vehicle in a while; Tesla’s most recent shareholder deck says it is still in development.</p>\n<p><b>FUTURE PRODUCT</b></p>\n<p>In his&nbsp;Master Plan, Part Deux, Musk said Tesla’s line up would “cover the major forms of terrestrial transport.” Most expect a cheaper, $25,000 car made in China. But what else?&nbsp;A bus? Minivan? Has&nbsp;Tesla ever considered an electric bike? Tesla’s 3Q&nbsp;investor deck&nbsp;(see page 7) lists a “Future Product” in development.</p>\n<p>There also are the Tesla Energy products, including the Solar Roof and Powerwall for homeowners.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Shareholders Can Expect From Musk’s New Tesla Roadmap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Shareholders Can Expect From Musk’s New Tesla Roadmap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 21:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-01/what-shareholders-can-expect-from-musk-s-new-tesla-roadmap><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elon Musk tweeted early this week that he will be on Tesla’s next earnings call in January and provide an “updated product roadmap.” He’ll also talk about this year’s “supply chain nightmare.”\nMusk ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-01/what-shareholders-can-expect-from-musk-s-new-tesla-roadmap\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-01/what-shareholders-can-expect-from-musk-s-new-tesla-roadmap","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116584621","content_text":"Elon Musk tweeted early this week that he will be on Tesla’s next earnings call in January and provide an “updated product roadmap.” He’ll also talk about this year’s “supply chain nightmare.”\nMusk sees everything that the company does — including building new factories in Austin, Texas, and near Berlin — as Tesla products. So while he will likely focus on vehicles on the horizon, I expect we’ll get an update on the progress of the factories, too. We could also hear about any number of other products, including Tesla Insurance; fans might even be able to get a $50 whistle shaped like the Cybertruck, assuming it’s ever back in stock.\nTo review: Tesla currently makes the Model S, X, 3 and Y in Fremont, California, and the Model 3 and Y in Shanghai. Tesla also is building a new factory in Lathrop, California, for Megapack, its utility-scale battery product.\nHere’s a quick reminder of everything else that Tesla has unveiled and that customers and investors are eager for updates on.\nElon Musk presents the Tesla Cybertruck.\nCYBERTRUCK\nMusk unveiled the Cybertruck two years ago, in November 2019. Of all the vehicles on Tesla’s plate, the Cybertruck is the one that has generated the most interest. The idea is to make it in Austin, Texas, after the Model Y. Tesla’s website, which still takes fully refundable $100 deposits for the Cybertruck, says “you will be able to complete your configuration as production nears in 2022.” I would not be surprised if this timeline slips further.\nSEMI\nMusk unveiled the Semi truck four years ago, in November 2017. Musk has suggested the Semi is on hold until Tesla can make or source a new type of battery cell in high volume. The new, larger 4680 battery cells were one of the big highlights of Tesla’s “Battery Day” last year. Tesla is making the 4680s on a pilot line in Fremont, but also plans to procure them from long-time supplier Panasonic. In its third quarter earnings release, Tesla said that “the 4680 in-house cell project continues to progress. We are producing an increasing number of battery packs for testing purposes, and so far, the test results meet our current expectations.” That sounds promising, but volume production remains a work in progress.\nROADSTER\nThe big reveal at the Semi event in November 2017 was chief designer Franz von Holzhausen driving the next-generation Roadster out of the back of the Semi. We haven’t heard about this vehicle in a while; Tesla’s most recent shareholder deck says it is still in development.\nFUTURE PRODUCT\nIn his Master Plan, Part Deux, Musk said Tesla’s line up would “cover the major forms of terrestrial transport.” Most expect a cheaper, $25,000 car made in China. But what else? A bus? Minivan? Has Tesla ever considered an electric bike? Tesla’s 3Q investor deck (see page 7) lists a “Future Product” in development.\nThere also are the Tesla Energy products, including the Solar Roof and Powerwall for homeowners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609719537,"gmtCreate":1638325030356,"gmtModify":1638325030478,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609719537","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","JNJ":"强生","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874056301,"gmtCreate":1637714481399,"gmtModify":1637714481517,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874056301","repostId":"1182893164","repostType":4,"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871356520,"gmtCreate":1637028814072,"gmtModify":1637028814180,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871356520","repostId":"1140879609","repostType":4,"isVote":1,"tweetType":1,"viewCount":300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":845576794,"gmtCreate":1636356624992,"gmtModify":1636356625229,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>share for coins, like pls thanks [Smile]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>share for coins, like pls thanks [Smile]&nbsp;","text":"$Tiger Brokers(TIGR)$share for coins, like pls thanks [Smile]","images":[{"img":"https://static.tigerbbs.com/22af35a6ff42cdee5f0efd31078ece5f","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845576794","isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":602623987,"gmtCreate":1639016602360,"gmtModify":1639016602537,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602623987","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DJX":"1/100道琼斯","DOG":"道指反向ETF","BK4161":"工业机械","QLD":"纳指两倍做多ETF","BK4534":"瑞士信贷持仓","PFE":"辉瑞","TQQQ":"纳指三倍做多ETF","SWK":"美国史丹利公司","SDOW":"道指三倍做空ETF-ProShares","BK4533":"AQR资本管理(全球第二大对冲基金)","PSQ":"纳指反向ETF","BK4007":"制药","BK4566":"资本集团","NCLH":"挪威邮轮","UDOW":"道指三倍做多ETF-ProShares","QQQ":"纳指100ETF","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓",".DJI":"道琼斯","DXD":"道指两倍做空ETF",".IXIC":"NASDAQ Composite","BK4517":"邮轮概念",".SPX":"S&P 500 Index","CCL":"嘉年华邮轮","QID":"纳指两倍做空ETF","DDM":"道指两倍做多ETF","BK4142":"酒店、度假村与豪华游轮","SQQQ":"纳指三倍做空ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871356520,"gmtCreate":1637028814072,"gmtModify":1637028814180,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871356520","repostId":"1140879609","repostType":4,"isVote":1,"tweetType":1,"viewCount":300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607666146,"gmtCreate":1639533974599,"gmtModify":1639533974753,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607666146","repostId":"2191784951","repostType":4,"repost":{"id":"2191784951","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639522244,"share":"https://www.laohu8.com/m/news/2191784951?lang=&edition=full","pubTime":"2021-12-15 06:50","market":"us","language":"en","title":"Wall Street ends down, investors eye inflation and Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=2191784951","media":"Reuters","summary":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads ","content":"<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, investors eye inflation and Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, investors eye inflation and Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","SSO":"两倍做多标普500ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","AAPL":"苹果","BK4559":"巴菲特持仓","COMP":"Compass, Inc.","BK4550":"红杉资本持仓","SPY":"标普500ETF",".DJI":"道琼斯","BK4079":"房地产服务",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","OEX":"标普100","OEF":"标普100指数ETF-iShares","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","BK4539":"次新股","IVV":"标普500指数ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191784951","content_text":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads declines, financials rally\n* Indexes: Dow -0.30%, S&P 500 -0.75%, Nasdaq -1.14%\nDec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.\nThe fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&P 500 index hit an all-time closing high late last week.\nDeclines were led by megacap tech-related stocks, with Salesforce.com, Microsoft Corp, Adobe and Alphabet Inc pulling down the S&P 500 and Nasdaq.\nApple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.\nThe Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&P 500 lost 0.75% to 4,634.09.\nThe Nasdaq Composite dropped 1.14% to 15,237.64.\nData from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.\nAbout two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.\n\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"\nTen of the 11 major S&P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.\nBerkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&P 500 from falling further.\nMany investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.\n\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nInflation\nBeyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"\nPfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.\nVolume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":883233834,"gmtCreate":1631242099728,"gmtModify":1631888951817,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DTST\">$Data Storage Corp.(DTST)$</a>🚀🚀","listText":"<a href=\"https://laohu8.com/S/DTST\">$Data Storage Corp.(DTST)$</a>🚀🚀","text":"$Data Storage Corp.(DTST)$🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883233834","isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":699450988,"gmtCreate":1639880353337,"gmtModify":1639880353512,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699450988","repostId":"2192754259","repostType":4,"repost":{"id":"2192754259","pubTimestamp":1639811460,"share":"https://www.laohu8.com/m/news/2192754259?lang=&edition=full","pubTime":"2021-12-18 15:11","market":"us","language":"en","title":"Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2192754259","media":"Motley Fool","summary":"Three names you know are trading within 10% of their 52-week lows. They deserve better.","content":"<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.</p>\n<p><b>Disney</b>&nbsp;(NYSE:DIS),<b> <a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>&nbsp;(NYSE:TWTR), and <b>Toast </b>(NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.</p>\n<h4><a href=\"https://laohu8.com/S/DIS\">Disney</a></h4>\n<p>Disney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.</p>\n<p>It's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.</p>\n<p>Disney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.</p>\n<p><b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b></p>\n<p>Another shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.</p>\n<p>The platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.</p>\n<h4><a href=\"https://laohu8.com/S/TOST\">Toast</a></h4>\n<p>Running a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.</p>\n<p>Toast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.</p>\n<p>Despite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 15:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4077":"互动媒体与服务","BK4550":"红杉资本持仓","BK4516":"特朗普概念","BK4561":"索罗斯持仓","BK4508":"社交媒体","BK4554":"元宇宙及AR概念","BK4106":"数据处理与外包服务","BK4532":"文艺复兴科技持仓","TWTR":"Twitter","DIS":"迪士尼","TOST":"Toast, Inc.","BK4524":"宅经济概念","BK4108":"电影和娱乐","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192754259","content_text":"The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.\nDisney (NYSE:DIS), Twitter (NYSE:TWTR), and Toast (NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.\nDisney\nDisney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.\nIt's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.\nDisney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.\nTwitter\nAnother shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.\nThe platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.\nToast\nRunning a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.\nToast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.\nDespite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1070,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821208123,"gmtCreate":1633744636588,"gmtModify":1633744895503,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Spurting]&nbsp;…….","listText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Spurting]&nbsp;…….","text":"$Aterian Inc.(ATER)$[Spurting] …….","images":[{"img":"https://static.tigerbbs.com/6631c04c8be441630296d19b94917af8","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821208123","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820524077,"gmtCreate":1633405342065,"gmtModify":1633405342243,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>Share for coins….[Sad]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>Share for coins….[Sad]&nbsp;","text":"$Aterian Inc.(ATER)$Share for coins….[Sad]","images":[{"img":"https://static.tigerbbs.com/c1529527bb2dad961d4a4c4b445def95","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820524077","isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":882868596,"gmtCreate":1631675311615,"gmtModify":1631890611286,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[{"img":"https://static.tigerbbs.com/af3cc7cf91d833f3124bf13fadb285bd","width":"750","height":"1869"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/882868596","isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881605551,"gmtCreate":1631327888673,"gmtModify":1631888951794,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DTST\">$Data Storage Corp.(DTST)$</a>🥳🚀🚀","listText":"<a href=\"https://laohu8.com/S/DTST\">$Data Storage Corp.(DTST)$</a>🥳🚀🚀","text":"$Data Storage Corp.(DTST)$🥳🚀🚀","images":[{"img":"https://static.tigerbbs.com/553b2243e8e7e9d66c3c5be91cf8b060","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/881605551","isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":606277130,"gmtCreate":1638889423729,"gmtModify":1638889423903,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Okay&nbsp;//<a href=\"https://laohu8.com/U/3574754838536636\">@Ameliakoh</a>:Pls like","listText":"Okay&nbsp;//<a href=\"https://laohu8.com/U/3574754838536636\">@Ameliakoh</a>:Pls like","text":"Okay //@Ameliakoh:Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606277130","repostId":"2189899796","repostType":4,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608554874,"gmtCreate":1638764447008,"gmtModify":1638764447128,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"💪💪","listText":"💪💪","text":"💪💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608554874","repostId":"1127164143","repostType":4,"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603670645,"gmtCreate":1638408797572,"gmtModify":1638408797816,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603670645","repostId":"1116584621","repostType":4,"repost":{"id":"1116584621","pubTimestamp":1638366346,"share":"https://www.laohu8.com/m/news/1116584621?lang=&edition=full","pubTime":"2021-12-01 21:45","market":"us","language":"en","title":"What Shareholders Can Expect From Musk’s New Tesla Roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=1116584621","media":"Bloomberg","summary":"Elon Musk tweeted early this week that he will be on Tesla’s next earnings call in January and provi","content":"<p>Elon Musk&nbsp;tweeted&nbsp;early this week that he will be on Tesla’s next earnings call in January and provide an “updated product roadmap.” He’ll also talk about this year’s “supply chain nightmare.”</p>\n<p>Musk sees everything that the company does — including building new factories in Austin, Texas, and near Berlin — as Tesla products. So while he will likely focus on vehicles on the horizon, I expect we’ll get an update on the progress of the factories, too. We could also hear&nbsp;about any number of other products, including&nbsp;Tesla Insurance; fans might even be able to get a&nbsp;$50 whistle&nbsp;shaped like the Cybertruck, assuming it’s ever back in stock.</p>\n<p>To review: Tesla currently makes the Model S, X, 3 and Y in Fremont, California, and the Model 3 and Y in Shanghai. Tesla also is building a new factory in Lathrop, California, for Megapack,&nbsp;its utility-scale battery product.</p>\n<p>Here’s a quick reminder of everything else that Tesla has unveiled and that customers and investors are eager for updates on.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/35dc043d86f20335c3ce1e3d7ee1e5f9\" tg-width=\"1024\" tg-height=\"599\" width=\"100%\" height=\"auto\"><span>Elon Musk presents the Tesla Cybertruck.</span></p>\n<p><b>CYBERTRUCK</b></p>\n<p>Musk unveiled the Cybertruck two years ago, in November 2019. Of all the vehicles on Tesla’s plate, the Cybertruck is the one that has generated the most interest. The idea is to make it in Austin, Texas, after the Model Y. Tesla’s website, which still takes fully refundable $100 deposits for the Cybertruck, says “you will be able to complete your configuration as production nears in 2022.” I would not be surprised if this timeline slips further.</p>\n<p><b>SEMI</b></p>\n<p>Musk unveiled the Semi truck four years ago, in November 2017. Musk has suggested the Semi is on hold until Tesla can make or source a new type of battery cell in high volume. The new, larger 4680 battery cells were one of the big highlights of Tesla’s “Battery Day” last year. Tesla is making the 4680s on a pilot line in Fremont, but also plans to procure them from long-time supplier Panasonic. In its third quarter earnings release, Tesla said that “the 4680 in-house cell project continues to progress. We are producing an increasing number of battery packs for testing purposes, and so far, the test results meet our current expectations.” That sounds promising, but volume production remains a work in progress.</p>\n<p><b>ROADSTER</b></p>\n<p>The big reveal at the Semi event in November 2017 was chief designer Franz von Holzhausen driving the next-generation Roadster out of the back of the Semi. We haven’t heard about this vehicle in a while; Tesla’s most recent shareholder deck says it is still in development.</p>\n<p><b>FUTURE PRODUCT</b></p>\n<p>In his&nbsp;Master Plan, Part Deux, Musk said Tesla’s line up would “cover the major forms of terrestrial transport.” Most expect a cheaper, $25,000 car made in China. But what else?&nbsp;A bus? Minivan? Has&nbsp;Tesla ever considered an electric bike? Tesla’s 3Q&nbsp;investor deck&nbsp;(see page 7) lists a “Future Product” in development.</p>\n<p>There also are the Tesla Energy products, including the Solar Roof and Powerwall for homeowners.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Shareholders Can Expect From Musk’s New Tesla Roadmap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Shareholders Can Expect From Musk’s New Tesla Roadmap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 21:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-01/what-shareholders-can-expect-from-musk-s-new-tesla-roadmap><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elon Musk tweeted early this week that he will be on Tesla’s next earnings call in January and provide an “updated product roadmap.” He’ll also talk about this year’s “supply chain nightmare.”\nMusk ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-01/what-shareholders-can-expect-from-musk-s-new-tesla-roadmap\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-01/what-shareholders-can-expect-from-musk-s-new-tesla-roadmap","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116584621","content_text":"Elon Musk tweeted early this week that he will be on Tesla’s next earnings call in January and provide an “updated product roadmap.” He’ll also talk about this year’s “supply chain nightmare.”\nMusk sees everything that the company does — including building new factories in Austin, Texas, and near Berlin — as Tesla products. So while he will likely focus on vehicles on the horizon, I expect we’ll get an update on the progress of the factories, too. We could also hear about any number of other products, including Tesla Insurance; fans might even be able to get a $50 whistle shaped like the Cybertruck, assuming it’s ever back in stock.\nTo review: Tesla currently makes the Model S, X, 3 and Y in Fremont, California, and the Model 3 and Y in Shanghai. Tesla also is building a new factory in Lathrop, California, for Megapack, its utility-scale battery product.\nHere’s a quick reminder of everything else that Tesla has unveiled and that customers and investors are eager for updates on.\nElon Musk presents the Tesla Cybertruck.\nCYBERTRUCK\nMusk unveiled the Cybertruck two years ago, in November 2019. Of all the vehicles on Tesla’s plate, the Cybertruck is the one that has generated the most interest. The idea is to make it in Austin, Texas, after the Model Y. Tesla’s website, which still takes fully refundable $100 deposits for the Cybertruck, says “you will be able to complete your configuration as production nears in 2022.” I would not be surprised if this timeline slips further.\nSEMI\nMusk unveiled the Semi truck four years ago, in November 2017. Musk has suggested the Semi is on hold until Tesla can make or source a new type of battery cell in high volume. The new, larger 4680 battery cells were one of the big highlights of Tesla’s “Battery Day” last year. Tesla is making the 4680s on a pilot line in Fremont, but also plans to procure them from long-time supplier Panasonic. In its third quarter earnings release, Tesla said that “the 4680 in-house cell project continues to progress. We are producing an increasing number of battery packs for testing purposes, and so far, the test results meet our current expectations.” That sounds promising, but volume production remains a work in progress.\nROADSTER\nThe big reveal at the Semi event in November 2017 was chief designer Franz von Holzhausen driving the next-generation Roadster out of the back of the Semi. We haven’t heard about this vehicle in a while; Tesla’s most recent shareholder deck says it is still in development.\nFUTURE PRODUCT\nIn his Master Plan, Part Deux, Musk said Tesla’s line up would “cover the major forms of terrestrial transport.” Most expect a cheaper, $25,000 car made in China. But what else? A bus? Minivan? Has Tesla ever considered an electric bike? Tesla’s 3Q investor deck (see page 7) lists a “Future Product” in development.\nThere also are the Tesla Energy products, including the Solar Roof and Powerwall for homeowners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609719537,"gmtCreate":1638325030356,"gmtModify":1638325030478,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609719537","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","JNJ":"强生","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874056301,"gmtCreate":1637714481399,"gmtModify":1637714481517,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874056301","repostId":"1182893164","repostType":4,"repost":{"id":"1182893164","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637708622,"share":"https://www.laohu8.com/m/news/1182893164?lang=&edition=full","pubTime":"2021-11-24 07:03","market":"us","language":"en","title":"HP rose over 8% in extended trading as it saw office reopenings lifting PC demand ahead of promising holiday season","url":"https://stock-news.laohu8.com/highlight/detail?id=1182893164","media":"Tiger Newspress","summary":"HP reported strong earnings and gave an upbeat outlook, aided by office reopenings and an expectatio","content":"<p>HP&nbsp;reported strong earnings and gave an upbeat outlook, aided by office reopenings and an expectation for healthy consumer demand through the holiday shopping season despite supply shortages.</p>\n<p>The company on Tuesday said it generated quarterly sales of $16.7 billion, up 9.3% from the year-ago period, and $3.1 billion in net income, including a one-time $1.78 billion legal settlement. The results beat Wall Street expectations for both sales and earnings.</p>\n<p>“We are seeing strong demand coming from the commercial side, from the office side because offices are reopening and companies are invested in creating a better experience for their employees,” HP Chief Executive Enrique Lores told The Wall Street Journal.</p>\n<p>Commercial PC revenue grew 25%, the company said, while consumer PC sales retreated 3%, from their lofty levels a year ago.</p>\n<p>HP said it expects to generate per-share earnings of $0.92 to $0.98 in the current quarter and $3.86 to $4.06 for the full fiscal year ending Oct. 31, 2022, both ahead of Wall Street expectations.</p>\n<p>The outlook, Mr. Lores said, is driven by “both sustained strong demand from the commercial side as we have seen this quarter but also by consumer demand being strong as we go through the holiday season.”</p>\n<p>Its&nbsp;stocks&nbsp;rose&nbsp;over&nbsp;8%&nbsp;in&nbsp;extended&nbsp;trading.<img src=\"https://static.tigerbbs.com/e89e6dba31d80fa622f70a2a247959e2\" tg-width=\"774\" tg-height=\"560\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HP rose over 8% in extended trading as it saw office reopenings lifting PC demand ahead of promising holiday season</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHP rose over 8% in extended trading as it saw office reopenings lifting PC demand ahead of promising holiday season\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 07:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HP&nbsp;reported strong earnings and gave an upbeat outlook, aided by office reopenings and an expectation for healthy consumer demand through the holiday shopping season despite supply shortages.</p>\n<p>The company on Tuesday said it generated quarterly sales of $16.7 billion, up 9.3% from the year-ago period, and $3.1 billion in net income, including a one-time $1.78 billion legal settlement. The results beat Wall Street expectations for both sales and earnings.</p>\n<p>“We are seeing strong demand coming from the commercial side, from the office side because offices are reopening and companies are invested in creating a better experience for their employees,” HP Chief Executive Enrique Lores told The Wall Street Journal.</p>\n<p>Commercial PC revenue grew 25%, the company said, while consumer PC sales retreated 3%, from their lofty levels a year ago.</p>\n<p>HP said it expects to generate per-share earnings of $0.92 to $0.98 in the current quarter and $3.86 to $4.06 for the full fiscal year ending Oct. 31, 2022, both ahead of Wall Street expectations.</p>\n<p>The outlook, Mr. Lores said, is driven by “both sustained strong demand from the commercial side as we have seen this quarter but also by consumer demand being strong as we go through the holiday season.”</p>\n<p>Its&nbsp;stocks&nbsp;rose&nbsp;over&nbsp;8%&nbsp;in&nbsp;extended&nbsp;trading.<img src=\"https://static.tigerbbs.com/e89e6dba31d80fa622f70a2a247959e2\" tg-width=\"774\" tg-height=\"560\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HPQ":"惠普"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182893164","content_text":"HP reported strong earnings and gave an upbeat outlook, aided by office reopenings and an expectation for healthy consumer demand through the holiday shopping season despite supply shortages.\nThe company on Tuesday said it generated quarterly sales of $16.7 billion, up 9.3% from the year-ago period, and $3.1 billion in net income, including a one-time $1.78 billion legal settlement. The results beat Wall Street expectations for both sales and earnings.\n“We are seeing strong demand coming from the commercial side, from the office side because offices are reopening and companies are invested in creating a better experience for their employees,” HP Chief Executive Enrique Lores told The Wall Street Journal.\nCommercial PC revenue grew 25%, the company said, while consumer PC sales retreated 3%, from their lofty levels a year ago.\nHP said it expects to generate per-share earnings of $0.92 to $0.98 in the current quarter and $3.86 to $4.06 for the full fiscal year ending Oct. 31, 2022, both ahead of Wall Street expectations.\nThe outlook, Mr. Lores said, is driven by “both sustained strong demand from the commercial side as we have seen this quarter but also by consumer demand being strong as we go through the holiday season.”\nIts stocks rose over 8% in extended trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870519989,"gmtCreate":1636632497240,"gmtModify":1636632497436,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GM\">$General Motors(GM)$</a>Like please, thanks [Smile]&nbsp;","listText":"<a href=\"https://laohu8.com/S/GM\">$General Motors(GM)$</a>Like please, thanks [Smile]&nbsp;","text":"$General Motors(GM)$Like please, thanks [Smile]","images":[{"img":"https://static.tigerbbs.com/deb851375d8aa1b0789e97cc99b47587","width":"750","height":"1924"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870519989","isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":840269752,"gmtCreate":1635650401821,"gmtModify":1635650401924,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840269752","repostId":"1160516340","repostType":4,"repost":{"id":"1160516340","pubTimestamp":1635576015,"share":"https://www.laohu8.com/m/news/1160516340?lang=&edition=full","pubTime":"2021-10-30 14:40","market":"sh","language":"en","title":"5 Stocks For Halloween: Will They Be Tricks Or Treats?","url":"https://stock-news.laohu8.com/highlight/detail?id=1160516340","media":"Benzinga","summary":"Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the ","content":"<p>Halloween will be celebrated on Sunday and could see significant changes from the 2020 event&nbsp;in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.</p>\n<p>Here’s a look at what the data is pointing to for 2021 Halloween spending and five stocks to keep on the radar that could turn in strong quarters that include the holiday.</p>\n<p><b>Halloween Sales Expectations:</b>Consumers feel more comfortable resuming normal Halloween activities according to theNational Retail Federation.</p>\n<p>“This year, two-thirds (65%) of consumers plan to celebrate <a href=\"https://laohu8.com/S/AONE.U\">one</a> of America’s favorite holidays, up from 58% in 2020,” NRF said.</p>\n<p>The NRF sees consumers spending an average of $102.74 this year on Halloween, which would be the first time the figure has hit triple digits. Estimates last year were for spending of $92.12 by each consumer.</p>\n<p>Research points to candy and costumes as big winners by the return of Halloween activities along with decorations. Spending on decorations is expected to hit $3.3 billion, an all-time high.</p>\n<p>Is <a href=\"https://laohu8.com/S/KO\">Coca-Cola</a>'s Stock Overvalued OrUndervalued?</p>\n<p>Halloween 2021 will also see a higher number of people without kids celebrating than in 2020. Estimates call for 55% of homes without children to celebrate, compared to 49% in 2020. The figure falls in line with pre-pandemic levels of anticipated adult costume spending.</p>\n<p><b><a href=\"https://laohu8.com/S/TR\">Tootsie Roll</a>:</b>Candy company<b><a href=\"https://laohu8.com/S/TR\">Tootsie Roll</a> Industries Inc</b></p>\n<p>TR-0.47%is a popular option for anyone handing out candy to trick or treaters. If you’ve ever gone trick or treating, chances are you got a ton of tootsie rolls, given their lower cost for anyone buying for a large number of visitors.</p>\n<p>The companyreportedthird-quarter sales of $183.1 million, up 17% year-over-year. The company saw a dip in fourth-quarter revenue last year compared to the prior year. Look for Tootsie Roll to see a rebound in the fourth quarter.</p>\n<p><b><a href=\"https://laohu8.com/S/HSY\">Hershey</a>:The <a href=\"https://laohu8.com/S/HSY\">Hershey</a> Co</b></p>\n<p>HSY-2.28%has diversified its products to include several snack brands, but candy remains the big revenue driver. The company owns many of the popular brands that will be sought out by trick or treaters. Hershey’sthird-quarterrevenue of $2.4 billion was the highest it has seen in years on a quarterly basis.</p>\n<p>“Consumer demand for our brands has remained robust,” Hershey Company CEO<b>Michele Buck</b>said. The company raised full-year sales guidance and a strong Halloween could help meet or exceed the updated expectations.</p>\n<p><b><a href=\"https://laohu8.com/S/JAKK\">Jakks Pacific</a>:</b>Toy company<b><a href=\"https://laohu8.com/S/JAKK\">Jakks Pacific</a> Inc</b></p>\n<p>JAKK-4.38%finds itself on the Halloween list thanks to its ownership of Disguise, the world’s leading costume design and manufacturing company. With more adults dressing up and a return of trick or treat activities, the company could be in for a strong quarter.</p>\n<p>The company’sthird-quarterrevenue was $237&nbsp;million, which included $64&nbsp;million in revenue for the costumes segment. Costume sales were up 16.4% year-over-year and the fourth quarter could continue that trend. Jakks Pacific had revenue of $128.3 million in the fourth quarter last year, a decline from the prior year. Last year’s fourth quarter featured a 91% year-over-year increase in costumes segment revenue. The third and fourth quarters are the company’s two biggest quarters for revenue.</p>\n<p><b>Party <a href=\"https://laohu8.com/S/CHCO\">City</a>:</b>Retailer<b>$Party <a href=\"https://laohu8.com/S/CHCO\">City</a> Holdco(PRTY)$ Inc</b></p>\n<p>PRTY+2.97%could be a popular destination for Halloween costumes and decorations. The company ended thesecond quarterwith 749 locations and is also a provider of third-party products to other retailers.</p>\n<p>Second-quarter revenue was up 110% year-over-year for the company.</p>\n<p>“We saw sequential acceleration of the business as the economy opened up and restrictions subsided, driving increased consumer ability to celebrate,” Party City CEO<b>Brad Weston</b>said. The company will report third-quarter earnings on Nov. 9, which could provide a better look at how the Halloween shopping looked.</p>\n<p><b><a href=\"https://laohu8.com/S/AMCX\">AMC Networks</a>:</b>Media company<b><a href=\"https://laohu8.com/S/AMCX\">AMC Networks</a></b></p>\n<p>AMCX-2.04%finds itself on the Halloween stock list thanks to its ownership of “The Walking Dead” franchise, horror film programming and as owner of horror focused streaming platform Shudder. AMC isairing“FearFest” from Oct. 1 through Oct. 31 on its namesake AMC and AMC+ channels, which could turn into a subscriber boosting event.</p>\n<p>“The Walking Dead” returned to the network with its final season beginning Oct. 10, which could be another October event to watch. Shudder, which is the largest horror focused streaming platform, is available for $4.75 a month on major streaming platforms. The platformhitone million subscribers in 2020. Pizza Hut, a<b><a href=\"https://laohu8.com/S/YUM\">Yum</a> Brands Inc</b></p>\n<p>YUM-0.75%company,partneredwith Shudder to offer a promotion for 30 days free.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks For Halloween: Will They Be Tricks Or Treats?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks For Halloween: Will They Be Tricks Or Treats?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-30 14:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.\nHere’s a ...</p>\n\n<a href=\"https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JAKK":"杰克仕太平洋","HSY":"好时","AMCX":"AMC网络公司","TR":"Tootsie Roll Industries Inc","CHCO":"City Holding Company"},"source_url":"https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160516340","content_text":"Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.\nHere’s a look at what the data is pointing to for 2021 Halloween spending and five stocks to keep on the radar that could turn in strong quarters that include the holiday.\nHalloween Sales Expectations:Consumers feel more comfortable resuming normal Halloween activities according to theNational Retail Federation.\n“This year, two-thirds (65%) of consumers plan to celebrate one of America’s favorite holidays, up from 58% in 2020,” NRF said.\nThe NRF sees consumers spending an average of $102.74 this year on Halloween, which would be the first time the figure has hit triple digits. Estimates last year were for spending of $92.12 by each consumer.\nResearch points to candy and costumes as big winners by the return of Halloween activities along with decorations. Spending on decorations is expected to hit $3.3 billion, an all-time high.\nIs Coca-Cola's Stock Overvalued OrUndervalued?\nHalloween 2021 will also see a higher number of people without kids celebrating than in 2020. Estimates call for 55% of homes without children to celebrate, compared to 49% in 2020. The figure falls in line with pre-pandemic levels of anticipated adult costume spending.\nTootsie Roll:Candy companyTootsie Roll Industries Inc\nTR-0.47%is a popular option for anyone handing out candy to trick or treaters. If you’ve ever gone trick or treating, chances are you got a ton of tootsie rolls, given their lower cost for anyone buying for a large number of visitors.\nThe companyreportedthird-quarter sales of $183.1 million, up 17% year-over-year. The company saw a dip in fourth-quarter revenue last year compared to the prior year. Look for Tootsie Roll to see a rebound in the fourth quarter.\nHershey:The Hershey Co\nHSY-2.28%has diversified its products to include several snack brands, but candy remains the big revenue driver. The company owns many of the popular brands that will be sought out by trick or treaters. Hershey’sthird-quarterrevenue of $2.4 billion was the highest it has seen in years on a quarterly basis.\n“Consumer demand for our brands has remained robust,” Hershey Company CEOMichele Bucksaid. The company raised full-year sales guidance and a strong Halloween could help meet or exceed the updated expectations.\nJakks Pacific:Toy companyJakks Pacific Inc\nJAKK-4.38%finds itself on the Halloween list thanks to its ownership of Disguise, the world’s leading costume design and manufacturing company. With more adults dressing up and a return of trick or treat activities, the company could be in for a strong quarter.\nThe company’sthird-quarterrevenue was $237 million, which included $64 million in revenue for the costumes segment. Costume sales were up 16.4% year-over-year and the fourth quarter could continue that trend. Jakks Pacific had revenue of $128.3 million in the fourth quarter last year, a decline from the prior year. Last year’s fourth quarter featured a 91% year-over-year increase in costumes segment revenue. The third and fourth quarters are the company’s two biggest quarters for revenue.\nParty City:Retailer$Party City Holdco(PRTY)$ Inc\nPRTY+2.97%could be a popular destination for Halloween costumes and decorations. The company ended thesecond quarterwith 749 locations and is also a provider of third-party products to other retailers.\nSecond-quarter revenue was up 110% year-over-year for the company.\n“We saw sequential acceleration of the business as the economy opened up and restrictions subsided, driving increased consumer ability to celebrate,” Party City CEOBrad Westonsaid. The company will report third-quarter earnings on Nov. 9, which could provide a better look at how the Halloween shopping looked.\nAMC Networks:Media companyAMC Networks\nAMCX-2.04%finds itself on the Halloween stock list thanks to its ownership of “The Walking Dead” franchise, horror film programming and as owner of horror focused streaming platform Shudder. AMC isairing“FearFest” from Oct. 1 through Oct. 31 on its namesake AMC and AMC+ channels, which could turn into a subscriber boosting event.\n“The Walking Dead” returned to the network with its final season beginning Oct. 10, which could be another October event to watch. Shudder, which is the largest horror focused streaming platform, is available for $4.75 a month on major streaming platforms. The platformhitone million subscribers in 2020. Pizza Hut, aYum Brands Inc\nYUM-0.75%company,partneredwith Shudder to offer a promotion for 30 days free.","news_type":1},"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840287404,"gmtCreate":1635650186159,"gmtModify":1635653461117,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Sweats]&nbsp;[Speechless]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Sweats]&nbsp;[Speechless]&nbsp;","text":"$Tiger Brokers(TIGR)$[Sweats] [Speechless]","images":[{"img":"https://static.tigerbbs.com/ee41815297bee4e8945f8cc768c309a4","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840287404","isVote":1,"tweetType":1,"viewCount":85,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":823921253,"gmtCreate":1633573039276,"gmtModify":1633573693008,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Sad]&nbsp;[Speechless]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Sad]&nbsp;[Speechless]&nbsp;","text":"$Aterian Inc.(ATER)$[Sad] [Speechless]","images":[{"img":"https://static.tigerbbs.com/d73ddcd6660d0e6bb8fcdfae73f12442","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823921253","isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":866958043,"gmtCreate":1632727251682,"gmtModify":1632798271226,"author":{"id":"3578285722323782","authorId":"3578285722323782","name":"JG_7","avatar":"https://static.tigerbbs.com/943a617088822556a2e8fdb01023a8dd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578285722323782","authorIdStr":"3578285722323782"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XNET\">$Xunlei(XNET)$</a>share share","listText":"<a href=\"https://laohu8.com/S/XNET\">$Xunlei(XNET)$</a>share share","text":"$Xunlei(XNET)$share share","images":[{"img":"https://static.tigerbbs.com/b3a11a60683524c8d45e6ab01f9cd748","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866958043","isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}